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I. The aims and outline of the thesis 
The number of diseases caused by mutations in a single gene is estimated to be over 
6,000. The Online Mendelian Inheritance in Man (OMIM) database includes 2,715 
phenotypes with a known molecular basis.
1
 Thus, the genetic basis of at least half of 
the known Mendelian disorders remains a mystery. Technological and scientific 
progress has recently enabled researchers to focus on complex disorders that are 
more common and therefore represent a bigger social problem. Although single gene 
diseases are rare, in total they affect around 1% of the population. Knowing the 
genetic basis of these diseases will help to diagnose them, to design evidence-based 
therapeutic approaches, and to perform clinical trials with new therapies. 
Primary ciliary dyskinesia (PCD) is a rare genetic disease characterized by 
recurrent respiratory tract infections, bronchiectasis and infertility. Pulmonary 
symptoms occur in PCD because of a lack of an efficient mucociliary clearance 
caused by the kinetic dysfunction of respiratory cilia. Male infertility is caused by 
immotility of flagella in spermatozoids. Female subfertility is caused by dysfunction 
of motile cilia in the fallopian tubes, which help to move the ovum toward the 
uterus. The disease is genetically heterogeneous - mutations in many different genes 
have a similar functional effect on the motility of cilia and cause identical or similar 
phenotypes. Despite the fact that mutations in twelve genes have already been found 
in PCD patients, the genetic background is still unknown in most cases.  
 We undertook two different strategies in an attempt to elucidate the 
pathogenesis of PCD (figure 1). We applied a classical genetic approach to look for 
new PCD loci and genes using linkage analysis and candidate gene sequencing. We 
also used a functional genomics approach to find new disease-associated pathways 
and functionally related genes in a genome-wide gene expression experiment. 
The primary research strategies for identifying genes causing Mendelian 
disorders have been positional cloning, physical mapping, and candidate-gene 
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sequencing. Linkage analysis reveals polymorphic genetic markers that are inherited 
through family pedigrees together with the disease. We performed linkage analysis 
on several small families with PCD and tried to deal with the genetic heterogeneity 
by phenotypical stratification of the patients. Most of the families were of Polish 
origin. We found significant linkage to chromosome 15q for a subtype of PCD 
called Kartagener syndrome. We followed up this finding by sequencing candidate 
genes in the region. The linkage analysis is described in chapter 2, while the fine 
mapping of the linkage region and the candidate-gene sequencing is described in 
chapter 3. 
Mendelian diseases are caused by mutations in a single gene. However, the 
mutations can affect the function of many other genes by altering the regulatory 
networks at the genomic level. The complexity of the ciliary structure and the 
multitude of genes involved in its functioning makes it extremely difficult to 
prioritize the candidate disease genes. We performed a pilot gene expression study 
in bronchial biopsies from PCD patients to find out if expression analysis can be 
useful in a search for new ciliary genes or pathways important to the disease patho-
mechanisms. We found significant down-regulation of ciliary genes in these 
biopsies. Moreover, we saw that ciliary genes have a highly correlated expression 
pattern across disease samples. We extracted the pattern by clustering analysis and 
used it to identify new ciliary genes, representing new PCD candidate genes spread 
throughout the genome. The the clustering analysis of the ciliary genes correlated 
expression is described in chapter 4, and the case-control comparison of the gene 
expression profiles in chapter 5. 
The main obstacle to finding frequently mutated PCD genes, seems to be the 
disease’s extensive genetic heterogeneity in the absence of phenotypical diversity. 
The final chapter discusses this problem in the light of new technological 
developments in genomics. I also outline some topics for future research and the 
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Primary ciliary dyskinesia (PCD) is a multisystem disease characterized by 
recurrent respiratory tract infections, sinusitis, bronchiectasis and male 
subfertility, associated in about 50% patients with situs inversus totalis (the 
Kartagener syndrome). The disease phenotype is caused by ultrastructural 
defects of respiratory cilia and sperm tails. PCD is a heterogenetic disorder, 
usually inherited as an autosomal recessive trait. So far, muta- tions in two 
human genes have been proved to cause the disease. However, the pathogenetics 
of most PCD cases remains unsolved. In this review, the disease 
pathomechanism is discussed along with the genes that are or may be involved 
in the pathogenesis of primary ciliary dyskinesia and the Kartagener syndrome. 
 
Introduction 
Primary ciliary dyskinesia (PCD), formerly known as the immotile cilia syndrome 
(ICS), belongs to a relatively small group of human genetic disorders caused by 
dysfunctions of particular organelles, analogous to mitochondrial, lysosomal or 
peroxisomal diseases. In 1933, four cases of coexisting situs inversus, bronchiectasis, 
and chronic sinusitis were described.
1 
Later this set of symptoms was named the 
Kartagener triad or Kartagener syndrome. In the 1970’s it was found that the 
mobility of flagella in the sperm and cilia in the respiratory endothelium of males 
with the Kartagener syndrome was impaired, causing both chronic 
bronchopulmonary symptoms and male infertility. This mobility impairment was due 
to ciliary ultrastructure defects that could be observed under the electron 
microscope.
2, 3
 Afzelius et al.
2
 coined the term “immotile cilia syndrome”, which 
has been replaced by the currently used “primary ciliary dyskinesia”. 
 All forms of PCD are characterized by dysmotility or immotility of 




4, 5, 6, 7 
To differentiate this inherited syndrome from the ultrastructural 
ciliary abnormalities observed during or after injuries (e.g. respiratory infections), 
the term “secondary ciliary dyskinesia” (SCD) is used for the acquired forms of the 
disorder.
8, 9
 The Kartagener syndrome (KS), where situs inversus, a mirror reversal 
of the usual left-right asymmetry of the abdominal and thoracic internal organ 




Cilia and flagella, organelles extending from the cell surface with which they share 
the cell membrane, are present on protozoan, animal and some plant cells. Flagella 
provide motility to unicellular organisms or cells such as spermatozoa. Cilia propel 
fluid over the epithelia of various organs. 
The main body of the organellum, called the axoneme, consists of 9 
peripheral microtubular doublets surrounding a central pair of microtubules (Figure 
1). Microtubular doublets are composed of heterodimers of and tubulin assembled 
into 13 and 11 protofilaments (in microtubules A and B, respectively). The 13 
protofilaments of the central microtubular pair are spatially oriented with respect to 
the central pair of the adjacent cilia. Radial spokes connect peripheral and central 
microtubules, while peripheral doublets are connected with each other by nexin 
links. Tubulins in the microtubules are accompanied by microtubule-associated 
proteins (MAPs). The most extensively studied MAPs are dyneins, which form 
inner (IDA) and outer (ODA) dynein arms extending from microtubul A of each 
doublet. In Chlamydomonas reinhardtii IDAs are arranged along the longitudinal 
axis of microtubule A, with a 96 nm long repeat pattern. Seven distinct IDA 
isoformes containing eleven dynein heavy chains, numerous intermediate and 
light chains are known. In the same alga a single isoform of ODA containing three 
heavy, two intermediate and eight light chains, is repeated every 24 nm along the 
axoneme. The axoneme at its basis is connected with the kinetosome (basal body) 
consisting of nine microtubular triplets, two of them continuous with axonemal 
microtubule A and B. The tubulin-dynein complex, typical for the inner structure 
13 
 
of cilia and flagella, constitutes a functional equivalent of the myofibrillar actin-
myosin complex. In the presence of ATP the dyneins, attached on one end to 
microtubule A, bind to microtubule B of the adjacent doublet and move towards 
its minus end, providing a mechanism for sliding between the two doublets. 
Single cilia lacking the central pair of microtubules (the 9 + 0 structure), 
called also primary cilia or monocilia, are present on the surface of ganglion cells, 
the pineal gland, the adrenal gland, the pancreas, the liver, the kidney, the heart, 
cartilages, the connective tissue, the dermis, the epidermis and some fetal cells. 
Monocilia act as sensory organelles, displaying receptor molecules (e.g. kidney 
principal cells) and initiate fluid flow (e.g. in the embryonal node). 
 
Figure 1. Schematic representation of a cross section of a ciliary axoneme 
Cilia and flagella are not only motile but also dynamic in terms of their 
structure. Within six hours, steady state flagella of Chlamydomonas reinhardtii 
exchange nearly 20% of their proteins. In a process called intraflagellar transport, 
14 
 
axonemal structural proteins are transported from the cytoplasm toward the tip of a 
flagellelar microtubule, where the assembly process occurs. A number of other 
proteins, including kinesin II (heterotrimeric kinesin, a member of the KIF3 motor 
protein family) are responsible for this transfer. The components moved by kinesin 





Left-right (LR) asymmetry determination is believed to occur in four steps: (1) 
initial breaking of the bilateral symmetry of the embryo, (2) the establishment of 
asymmetric gene expression within the embryonic organizer (node), (3) the 
transfer of the asymmetrical signals from the embryonic organizer to the lateral 




 The node (organizer), a separate structure at the distal tip of the 
gastrulating embryo, is the mammalian equivalent of the Hensen node in 
chickens and the Spemann organizer in Xenopus. It remains in direct contact with 
the ectoand endoderm and is a major organizing center that regulates pattern 
formation in early-stage embryos. The node is essential for both gastrulation and 
the body axes formation. The  “organizing” function is restricted to the 
endodermal, ventral cells of the node. Each ventral node cell carries a single cilium 
(monocilium) pointing from the embryo into the extracellular fluid.
12
 
Monocilia generate the vortical leftward flow of the extraembryonic fluid 
in the node region. This flow is supposed to asymmetrically distribute hypothetical 
morphological inducers, thus providing a mechanism for the initial breaking of 
symmetry, triggering a different activation of signaling pathways and gene 
expression on the left and right side of the node.
13, 14, 15
 During the following steps, 
the asymmetrical information, encoded by the differential pattern of gene expression, 





A complicated and still not entirely understood network of protein 
interactions is responsible for preventing the contra-lateral spread of the asymmetric 
signaling cascade in the embryo. Maintaining the embryonic midline barrier 
provides an additional mechanism stabilizing the asymmetrical gene expression. A 
differential expression pattern of several factors has been identified in different 




Another, two–cilia model of asymmetry determination has been recently 
proposed.
19,20
 In this model, the node contains two distinct classes of the primary 
cilia: flow-generating motile cilia and flow-detecting mechanosensory cilia. Based 
on the similarity with the kidney mechanosensorycilia, where polycystin-1 and 
polycystin-2
21,22,23
 have been shown to form membrane calcium channels, ciliary 
signaling in the embryonic node could be coupled to intracellular calcium 
signaling. At the end of this signal transduction pathway, specific factors would be 
released on the left side of the node, where the flow remains the strongest. 
Data supporting the ciliary fluid flow hypothesis come from the studies of 
murine inversus viscerum (iv) mutants, harboring mutations in a ciliary component, 
the left-right dynein (the protein product of lrd).
18
 The iv mice have immotile nodal 
monocilia, fail to generate the nodal flow and exhibit situs randomization.
15
 
However, other murine mutants, called the inversion of embryonic turning (inv), 
cannot be explained by a “single-cilia” model, since they exhibit nearly 100% 
incidence of situs inversus and the direction of the nodal flow is not altered in 
those mutants.
15, 24
 Inversin (the protein product of inv) has been localized in the 
centrioles, in the primary cilium and in the anaphase-promoting complex, and 
proposed to link the mechanosensory function of the monocilia with the cell cycle. 
In KS families affected siblings with situs inversus and situs solitus can be 




Epidemiology and genetics of PCD/KS 
Estimates of PCD prevalence range from 1/15,000 to 1/60,000 live births
5
; other 
estimates place PCD prevalence at the level of 1/12,500.
25, 26
 Since about half of the 
PCD cases display situs inversus, the incidence of KS is estimated to range 
between 1/30,000 and 1/120,000 live births (or 1/25,000). It is certain that the 
disease frequency is markedly underestimated, especially when PCD patients 
with the usual visceral arrangement (CDO, ciliary disfunction only) are 
concerned. The absence of the mirror image arrangement of the organs, renders 
diagnosis more difficult and CDO patients are often diagnosed later, if at all. 
Inheritance in most cases appears to be autosomal recessive,
2, 4, 5
 although 




All the symptoms of PCD are caused by functional defects of the cilia, 
classified as dysmotility or immotility. Eighteen different ultrastructural defects 
underlying PCD have been characterized, among them: the most common outer 
dynein arm defects, inner dynein arm defects, microtubule transpositions, radial 
spokes defects, and the absence of nexin links. In 10-20% of patients no 
ultrastructural defects can be found in electron microscopy, although their cilia are 
immotile. 
PCD is the first human disorder known to be caused by a primary 
dysfunction of the ciliary apparatus. Recently, two other disorders have been 
pathomechanically linked to the epithelial cilia. Polycystic kidney disease is caused 
by the impairment of intraflagellar transport in the non–motile primary cilia of 
kidney epithelial cells.
30
 Outer segments of retinal photoreceptors are formed from 
the primary cilia. In a mature photoreceptor, a short fragment of a cilium called the 
connecting cilium, remains between the outer and inner segment of cones and rods. 
In a process, similar to the intraflagellar transport, opsin is moved from the inner 
segments of the rod and cones toward their outer segments via the connecting 
17 
 
cilium; its defect is believed to be the main cause of RP.
31, 32
 The genetic basis of a 
variety of defects affecting ciliary structure and function in PCD is not clear. 
Approximately 250 different polypeptides have been identified in the ciliary 
axoneme of lower organisms. At least the same number of proteins can be 
expected in the axonemes of humans.
33
 It is rather unlikely that mutations of as many 
as 250 different genes coding for various ciliary proteins cause the same or similar 
pathologic consequences of the ciliary dysfunction. If that was true, one might expect 
the incidence of PCD to be much higher than actually reported.
3
 It is possible that 
many ciliary protein gene mutations may be lethal even if heterozygous. On the 
other hand, mutations in other genes may not affect ciliary function at all, perhaps 
due to the redundancy of functions of common gene families such as dyneins. In any 
case, the low incidence of KS and PCD suggests that perhaps mutations in only a 
small number of these genes underlie the diseases. Two strategies can be applied to 
map genes causing PCD. One, a candidate gene approach, consists in studying genes 
selected based on their purported ciliary function or animal/plant models of the 
disease. The second strategy, linkage studies, consist in looking for genomic markers 
linked with the disease in PCD families (Table 1). 
 
Table 1. PCD genes, candidate genes and chromosomal regions indicated by 
different     mapping strategies 
Chromosomal region Gene Disease involvement Animal model Linkage References 
1p35.1 HP28  Chlamydomonas 
reinhardtii p28 
 61 
2p14-q14.3 CFC1 heterotaxy   75 
2q33.1 DNAH7    60 
2q34 hPF20  Chlamydomonas 
reinhardtii p20 
 62 
3p21.3 DNAH1  murine Mdhc7 
mutants 
 58 
4q* -   PCD 94 
5p15-p14 DNAH5 PCD murine Mdnah5 
mutants 
PCD 45 
5q31 KIF3A  murine Kif3a null 
mutants 
 14 
6p21.3 HLA region (TUBB, 
MLN, KNSL2, HSET) 
  PCD 67, 70 





7p15 DNAH11 PCD murine iv/iv mutants  49, 51 
7q33-q34 -  murine hop mutants  34 
8q* -   PCD 94 
9p13-21 DNAI1 PCD Chlamydomonas 
reinhardtii IC78 
 41, 42 
9q31 INV Nephronophthis murine inv mutants  80, 81 
10p* -   PCD 94 
10q24 DPCD  murine Poll mutants  43 
11q* -   PCD 94 
13q* -   PCD 94 
13q12.1 Tg737  murine models of 
PKD with SI 
 83 
14q32 EMAPL Usher syndrome 1a   94, 65 
15q13.1-15.1 -   PCD 93 
15q24 -   KS 95 
16p12.1-12.2 -   PCD 93 
16pter* -   PCD 94 
17p12 (17q25) DNAH9  murine iv/iv mutants  53 
17q* -   PCD 94 
17q22-q25 HFH-4  murine Foxj1-/- 
mutants 
 89 
17q25 DNAI2  Chlamydomonas 
reinhardtii IC69 
 44 
19q13.3 RSHL1    74 










Xp11.4 RPGR   PCD with 
RP 
72, 73 
*results of a genome-wide low density linkage analysis 
 
Animal models of PCD/KS 
A number of animal models of PCD have been identified, including examples in 
the mouse (iv/iv, inv/inv, hop) ,
24, 34, 35







dogs (springer spaniels, English setters, Newfoundlands) and pigs have a relatively 
high incidence of a respiratory disease with the phenotype almost identical to the 
primary ciliary dyskinesia in humans, but in both species hydrocephalus is an 
additional prominent component of the syndrome. Chlamydomonas reinhardtii, a 
19 
 
unicellular alga with two flagella containing an axonemal structure similar to that of 
the human respiratory cilia and sperm tails, became a good model for the studies 
of mutational events related to ciliary ultrastructural abnormalities.
40
 Studies on 
some of these models helped to focus attention on particular regions of the human 
genome that contain homologues of the genes involved in animal PCD models, 
thus creating a list of candidate genes and possible chromosomal locations to be 
taken into account in genetic mapping of human PCD. So far, eleven genes been 
screened for mutation (Table 2) and two genes have been identified, in which 
mutations underlying the ultrastructural phenotype were found in PCD patients 
(DNAI, DNAH5); the third gene should be considered as a possible candidate 
(DNAH11). 
Table 2. PCD candidate genes screened for mutation. 
Gene Mutations detected Ciliary localization 
 
L-R asymmetry Ultrastructural defect Reference 
HP28 ND Inner dynein arms NK NK 61 
DNAH5 in 8 PCD\KS families Outer dynein arms SS, SI Outer dynein arms absence 46 
DNAI1 in 1 PCD family 
in 2 PCD\KS families 
in 3 KS families 
Outer dynein arms SS,SI Outer dynein arms absence 41, 42, 43 
DNAH9 ND NK NK NK 53 
DNAH11 in 1 CF/PCD patient Outer dynein arms SI none 49 
hPF20 ND Central complex 
microtubules 
NK NK 62 
TCTE3 ND Outer dynein arms NK NK 63 
HFH-4 ND NK NK NK 89 
DPCD ND NK NK NK 43 
DNAH7 ND Inner dynein arms NK NK 60 
DNAI2 ND Outer dynein arms NK NK 44 
SI – situs inversus; SS – situs solitus; ND – not detected; NK – not known 
 
DNAI1 (chromosome 9p13-21) 
DNAI1, a human homologue of the Chlamydomonas reinhardtii gene IC78, was 
the very first human gene, in which mutations causing the ultrastructural 
phenotype were described in PCD patients.
41
 DNAI1, located at 9p13-21, is highly 
20 
 
expressed in the trachea and testes and is composed of 20 exons. This gene 
encodes a dynein intermediate chain type 1, found in the outer dynein arms (ODA). 
Originally two loss-of-function mutations of this gene have been identified in a 
patient with PCD characterized by immotile cilia lacking ODA: (i) maternal 
insertion of four nucleotides in exon 5, causing a frameshift; and (ii) paternal T 
insertion at +3 position of the intron 1 donor site resulting in the absence of splicing. 
Both mutations generate severely truncated polypeptides lacking 85% and 95% of 
the DNAI1 protein, respectively. However, linkage between this gene and PCD 
has been excluded in five other families, demonstrating locus heterogeneity of the 
disease. Further studies of a number of KS families
42
 and PCD/KS families with 
ODA defects
43
 revealed four other mutations of the DNAI1 gene: (iii) transition G 
to A (position 1714or5) in exon 16, resulting in a G515S substitution, removing 
highly conserved glycine, a potential N-myristoylation site; (iv) 12 bp deletion in 
exon 17, resulting in protein truncation, removing a highly conserved phenylalanine 
at position 556; (v) G1874C transversion leading to a missense mutation 
(W568S); (vi) G1875A transition leading to a nonsense mutation (W568X). The 
last two mutations were present at the conserved tryptophan residue in the WD-
repeat region which is predicted to lead to an abnormal folding of the DNAI1. The 
splice defect caused by the T insertion in intron 1 is the most common mutation 
present on one allele in all the cases analysed so far. Mutations of the DNAI1 
cause either situs solitus (normal) or situs inversus. 
The other human gene coding for dynein intermediate chain 2 (DNAI2), 
located at 17q25, with a similar pattern of tissue specificity of expression, showed 




DNAH5 (chromosome 5p15-5p14) 
A total genome scan, performed in a large consanguineous family of Arab origin 
with the Kartagener syndrome and the absence of outer dynein arms, pointed to a 
region on chromosome 5p15-5p14 as being linked to the disease. A murine 
21 
 
chromosomal region on chromosome 15, which is syntenic to human 
chromosome 5p and 8q, contains a gene for a heavy chain of axonemal dynein. 
Further experiments have led to the isolation of the human gene DNAH5, coding for 
an axonemal dynein heavy chain 5. Homology search revealed a high sequence 
conservation between human DNAH5 protein and Chlamydomonas reinhardtii 
axonemal dynein heavy chain gamma.
45
 Sequencing of the overlapping cDNA 
fragments from the human testes and trachea resulted in the characterization of the 
13872 nucleotide open reading frame encoding 4624 aminoacids. DNAH5 is 
composed of 79 exons and is expressed in the lung, the kidney, and, at a lower 
level, in the brain, heart and testes. 
Sequencing of the entire coding region in several PCD families (selected 
following the analysis of a haplotype composed of intragenic polymorphic markers) 
revealed four homozygous mutations and six heterozygous mutations in eight 
families; in two cases, no mutations were revealed on the second allele.
46
 Seven 
nucleotide changes introduced a premature stop codon, resulting in peptides 
lacking motor domains and microtubule binding domains; in addition, two 
missense mutations in the conserved domains and one splice-site mutation were 
found. From seventeen individuals carrying mutations in DNAH5, seven displayed 
situs inversus. The occurrence of individuals with situs inversus and situs solitus 
within the same family strengthens the hypothesis of the left-right asymmetry 
randomization in patients with ciliary defects. 
Dnahc5, a murine equivalent of human DNAH5, was shown by in situ 
hybridization to be present in the embryonic ventral node between 7th and 8th day 
after conception; this confirms its role in the early stages of embryogenesis. DNAH5 
is the first axonemal protein confirmed to play an essential role in both embryonic 
cilia and lung cilia functioning.
46
 
Recently, a genotype-phenotype correlation for this gene was reported. 
Results of the electron microscopy of the respiratory cilia from individuals harboring 
a premature translation termination mutation in DNAH5 were compared with 
22 
 
patients with a splice-site mutation in DNAH5. In the former case, cilia displayed a 
complete absence of ODA. Ultrastructural findings in the individuals with splice site 
mutations showed only a partial loss of ODA.
47
 
DNAH11 (chromosome 7p21) 
The gene for a heavy dyneine chain of the outer dynein arms maps to the 7p15 
region
48
, and clones containing sequences homologous to the dynein gene family 
map to 7q21-q22. The third gene documented in the literature as likely to be causative 
of PCD, DNAH11 coding for human dynein heavy chain 11 mapped to chromosome 
7p21. Its homologue is mutated in the mouse iv/iv model of situs inversus.
49
 The 
mutation analysis of all the 40 exons of the human DNAH11 gene was performed 
and a homozygous nonsense mutation R2852X was identified in exon 52. The 
mutation was detected in a patient previously reported as having uniparental disomy 
of chromosome 7 (UPD7).
50
 The patient expressed complete situs inversus, 
motionless respiratory cilia and cystic fibrosis (due to the homozygous F508del 
mutation of the CFTR gene located on human chromosome 7). His mother was not 
a carrier of the CF mutation and both chromosomes 7 were inherited from his 
father (a documented CF carrier), as false maternity was excluded. Electron 
microscopy analysis in this patient revealed normal cilia and dynein arms, which is 
compatible with the nonsense mutation in the middle of the motor domain of a 
heavy dynein chain. The truncated mutant DNAH11 protein could theoretically be 
incorporated in the dynein arms but is inactive due to the lack of the microtubule-
binding domain. A question remains whether this particular patient really suffered 
from PCD or all the respiratory symptoms caused by CF, with situs inversus were 
only incidentally co-occurring in this case. 
Other genes/regions coding for axonemal structure proteins 
Linkage data obtained for PCD families recruited in Poland, strongly excluded a 
putative KS gene (at least for a high proportion of families studied) from all or 
most of chromosome 7.
51
 PCD families in that study were subclassified either as 
23 
 
KS families (if at least one PCD-affected member exhibited situs inversus) or as 
ciliary dysfunction only (CDO) families (if none of the affected members 
exhibited situs inversus). The KS and CDO families were analysed separately 
because of the possibility that different molecular pathologies could underlie these 
subtypes of PCD. Such a hypothesis is consistent with the fact that mice carrying 
the hop mutation that maps to a region syntenic to human 7q33-q34 exhibit CDO 
but not situs inversus. The results provided a weak suggestion of linkage in only the 
CDO subset of the PCD families. These linkage data concords with the existence 
of the DNAH11 mutation in the UPD7 patient described above, with PCD and 
normal situs.
49
 Human chromosome 7q33-q34 is syntenic to a fragment of mouse 
chromosome 6 containing the hop mutation (previously named hpy). In the 
homozygous form, this mutation causes a dynein-related defect in the cilia and 
flagella, similar to that seen in PCD and resulting e.g. in male infertility. In contrast 




In other studies, no mutations were detected in the DNAH9
53
 and in six 
other axonemal dynein heavy chain genes.
54
 The former was mapped by FISH 
and radiation hybrid analysis to 17p12
55, 56
; the alternative map position of this 
locus is 17q25.
57
 A mutation search performed in two families with the concordant 




Disruption, by homologous recombination, of the mouse dynein heavy chain 
7 gene (Mdhc7), a homologue of the human DNAH1, results in male infertility due 
to dramatically reduced sperm motility and in a ciliary beat frequency reduction, 
but not in defects in the axonemal structure of the tracheal cilia or sperm flagella.
58
 
DNAH1 was mapped to 3p21.3, which is syntenic to mouse chromosome 14 region 
B-C containing the Mdhc7 gene.
59
 
A comparative biochemical analysis of cilia from healthy subjects and a 
PCD patient with the absence of inner dynein arms has lead to the characterization 
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of DNAH7 as a part of IDA. Northern and Western blots indicated that both DNAH7 
mRNA and the protein itself were present in cells from this IDA-deficient patient. 
However, contrary to the healthy controls, the patient’s cells stained with the anti-
DNAH7 antibody showed an increase of the specific signal in the cytoplasm and its 
lack in cilia. The analysis of the DNAH7 sequence from the PCD patient has not 
revealed any mutations. It was hypothesized that PCD in this patient might result 
from a defect in the DNAH7 transport from the cytoplasm to the cilia.
60
 
Mutations in the Chlamydomonas p28 gene that encodes a dynein light 
chain, lead to the absence of inner dynein arms in the flagellar axonemes of this 
model organism. The analysis of HP28, a human p28 ortholog located at 1p35.1, 
has not resulted in the detection of any mutations in PCD patients studied.
61
 
Mutants of Chlamydomonas reinhardtii called pf20 have totally paralyzed 
flagella and display a complete lack of the central complex. One transcript variant 
from the human homologue, hPF20 gene, is expressed exclusively in the testes. 
Genomic localization of hPF20 was assigned to chromosome 2q34. No mutations 
have been revealed in the screening performed in four patients with PCD, situs 
solitus and the central complex defect, and in one infertile patient with the central 
complex defect and the absence of inner dynein arms in the sperm.
62
 
Mutants of Chlamydomonas reinhardtii called LC2 lack outer dynein arms 
and show a slow swimming phenotype. LC2 codes for a light dynein chain. Its 
murine homologue, Tcte3, was originally identified in the testes as a candidate 
gene for the involvement in the non-Mendelian transmission of mouse 
chromosome 17 variant forms, known as t-haplotypes. In this variant, Tcte3 had an 
aberrant sequence and sperm motility was reduced. Human TCTE3, located on 
6q25-q27, is expressed in ciliated tissues. Mutation screening of TCTE3 in 
patients with PCD have not revealed any sequence abnormalities.
63
 
EMAPL, the echinoderm microtubule-associated-protein-like gene, is 
located on human chromosome 14q32. Mutations in this gene have been shown to 
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cause the Usher syndrome type 1A; axonemes of the respiratory cilia in these 
patients sometimes exhibit ultrastructural defects similar to those observed in 
PCD.
64, 65 
The HLA region of chromosome 6p contains the tubulin gene (TUBB)
66
 
and was suggested to be linked to PCD in one study.
67
 However, the motilin gene 
(MLN), which also resides in this region, was not supported as a candidate for the 
involvement in PCD.
68, 69 
Another candidate located in the HLA region is the 
kinesin-like 2 gene (KNSL2).
70 
Kinesins are involved in ciliary beating
71
 and this gene 
is located at the centromeric end of the major histocompatibility complex. Four 
single-base substitutions were detected in the HSET gene (kinesin-related protein), 
mapped also to 6p21.3, in two PCD families studied.
70  
 RPGR (retinitis pigmentosa GTPase regulator) protein is a structural 
component of the connecting cilium in the retina but is also expressed in the testes and 
lungs. A mutation in the RPGR gene located on Xp21.1, responsible for 70% of the 
X-linked retinitis pigmentosa, has been reported to be associated in one family with 
retinitis pigmentosa (RP), hearing loss, and bronchosinusitis.
72
 Preliminary results 
might suggest theinvolvement of RPGR in the pathogenesis of particular cases of 
PCD/RP comorbidity.
28, 73 
Genes/regions involved in L-R asymmetry 
Candidate genes for PCD include a whole group of genes involved in the 
determination of the left/right asymmetry of internal organs. Left-right (L-R) axis 
abnormalities or laterality defects are relatively common in humans (1 in 8,500 
live births). It has to be emphasized, however, that the L-R asymmetry defects that 
are not linked with bronchopulmonary symptoms do not classify as PCD or KS. 
Only few genes associated with a small percentage of human situs defects 
have been identified. These include ZIC3,
7 4
 CFC1 (encoding the CRYPTIC 
protein) ,
75
 LEFTB (formerly LEFTY2)
76, 77
 and ACVR2B (encoding activin receptor 
IIB).
78
 Mutations in ZIC3 (chromosome 19q13.3-qter) and CFC1 (chromosome 
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It has been shown that proteins KIF3A and KIF3B of the kinesin 
superfamily determine the L-R asymmetry by participating in the assembly of the 
nodal cilia that produce the leftward nodal flow of an extra embryonic fluid in 
mouse embryos.
13, 14, 71 
Targeted mutagenesis of KIF3A and KIF3B kinesins results in 
the failure to assemble ciliary axonemes and causes a bilateral expression of factors 
normally expressed only on one side of the node.
79
 Murine embryos lacking KIF3A 
die after ten days. Electron microscopy shows the loss of cilia, normally present 
on the embryonic ventral node, and a bilateral expression of Pitx2, normally 
expressed only on the left side of the node. Mutant embryos display morphological 
and asymmetrical defects. Cardiac looping is normal, reversed or retarded.
31
 The 
KIF3B null mutants, totally lacking the KIF3B protein, do not survive beyond 
midgestation. Early mouse embryos exhibit growth retardation, pericardial sac 
ballooning and neural tube disorganization. Left-right asymmetry is randomized in 
the heart loop and the direction of embryonic turning. Lefty-2, normally present on 
the left side of the node, is expressed bilaterally or absent. The embryonic ventral 
node lacks cilia, but basal bodies are present.
13
 Genes of these proteins are located 
on human chromosomes 5q31 (KIF3A) and 20 (KIF3B). 
Mouse mutant inv (inversion of embryonic turning) is the only known 
murine mutation that causes almost 100% of homozygous embryos to develop 
situs inversus.
24
 These embryos do not survive and they have cardiovascular, renal 
and pancreatic defects; however, their respiratory cilia show no structural or 
activity abnormalities. The gene causing the inv mutation has been cloned; the 
protein, called inversin, contains ankyrin-like repeats and potential nuclear 
localization signals.
80
 This gene reverses the left-right pattern of expression of 
the nodal, lefty-1 and lefty-2 genes, suggesting that inversin acts upstream of these 
TGF-beta-like genes, which are also involved in the left-right asymmetry.
71
 In 
addition to the aberrant shape of the inv/inv node itself, the defective monocilia 
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rotate more rapidly than they normally do. Inversin has been shown to be strongly 
expressed in the primary cilia of the renal ducts. The human inversin gene (INV) is 
located on chromosome 9q31. Mutations in the INV have been detected in patients 
suffering from nephronophthisis (NPHP2), an autosomal recessive cystic kidney 
disease with or without situs inversus.
81
 In a study of heterotactic patients, a 
German family of Turkish origin has been described with all, both affected and 
non-affected, individuals heterozygous for a mutation in the donor splicing site of 
intron 12 in the INV gene, resulting in two different aberrant splicing isoforms. No 
complementing mutation was found in the affected; their phenotype has been 
therefore explained either by a randomization of the LR asymmetry, or by the di- or 
trigenic mode of inheritance.
82
 
 A transgenic mouse harboring an insertional mutation in the Tg737 gene 
displays a phenotype resembling the human recessive autosomal polycystic kidney 
disease.
30
 Tg737 encodes a tetratricorepeat protein Polaris. Embryos of knockout 
mice lacking Polaris have a defective LR development, with situs randomization 
and frequently the reverse direction of heart looping.
83
 The mutation is lethal: 
embryos do not survive longer than ten days. The Chlamydomonas homologue of 
Polaris functions in intraflagellar transport (IFT).
84
 The human Polaris homologue 
is encoded by the gene located on chromosome 13q12.1. The analysis of the human 
TG737 gene sequence in patients with the autosomal recessive form of the 
polycystic kidney disease did not reveal any mutations.
85
 
The mouse mutants iv/iv have laterality defects in 50% of offspring, but ciliary 
abnormalities have not been described.
86
 It has been shown that mutations of the lrd 
gene (encoding left/right dynein) are the cause of the iv and legless (lgl) mouse 
mutants, in which embryonic ventral node cilia are affected causing a randomization 
of the L-R  
asymmetry.
71, 87
 The region, to which the gene is likely to map in humans, is on 
chromosome 7q. This finding definitely confirms the role of the dynein protein 






 A link between ciliary motility and lateralization has been also provided by 
mouse mutants defective in genes required for ciliary growth and/or beating. A 
randomization of the L-R asymmetry due to a complete absence of cilia was 
observed in mice harborin a mutation in the hepatocyte nuclear factor 3/forkhead 
homologue-4 (Hfh-4, alias Foxj1) gene. Homozygous Foxj1 -/- mutants displayed 
a complete absence of respiratory cilia and spermatic flagella, and 50% of the 
animals revealed heterotaxy and situs inversus totalis. In addition, the expression of 
the left-right dynein (lrd) was not observed in the embryonic lungs of Foxj1 mutants, 
suggesting that Foxj1 may act by regulating the expression of dyneins.
88
 The 
human homologue, HFH-4, also called FKHL13 and recently renamed Foxj1, has 
been mapped to chromosome 17q22-q25. Members of the forkhead/winged-helix 
family of transcription factors, to which HFH-4 belongs, have specific tissue 
expression. HFH-4 has been detected in the epithelial cells of the lung, oviduct, 
choroid plexus and the ependyma of the brain and seminiferous tubules of the 
testes. Further studies with anti-HFH-4 antibodies revealed that the protein is 
localized in the ciliated cells of those tissues, but exclusively in the mobile cilia. 
During normal ciliogenesis the appearance of cilia follows HFH-4 expression, both 
in the mouse and the human. Mutation screening of the two exons and of intron-




Targeted mutagenesis of the murine gene coding for DNA polymerase 
caused hydrocephalus, situs inversus, chronic sinusitis and male infertility.
90
 The 
analysis of the genomic region surrounding the polymerase gene revealed the 
presence of another gene, Dpcd, on the opposite strand. The human homologue of 
this gene, DPCD, is expressed during ciliogenesis. No disease causing mutations 
were found in this gene in the PCD patients scanned.
43
 
Other PCD/KS-linked chromosomal regions and genes 
A high-density genomic scan of chromosome 15, using microsatellite markers 
specific for this chromosomal region, performed on a large number of the 
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Kartagener syndrome (KS) and ciliary dysfunction only (CDO) families of Polish 
origin,
51 
localized a putative KS gene to the chromosomal region of 15q24. In CDO 
families, linkage for this chromosomal location was negative, demonstrating 
locus heterogeneity dependent on the presence or absence of situs inversus among 
PCD individuals. 
A total genome scan in five PCD families of Arabic origin (a defect of 
ODA, four with reported consanguinity) defined a critical region of a possible PCD 
locus location on chromosome 19q13.3.
91
 Linkage was not found for this region 
in two of these families, again confirming locus heterogeneity. Chromosome 
19q13.3–qter is a gene-rich region containing at least two candidates for a PCD 
locus. One is the radial spokehead-like 1 gene (RSHL1), residing at the myotonic 
dystrophy locus. RSHL1, expressed in adult testes, codes for a radial spokehead-like 
protein characterized by high homology to proteins of the sea urchins and 
Chlamydomonas, important in the normal ciliary or flagellar action, including that of 
sea urchin spermatozoa.
92
 The other one, the ZIC3 locus, codes for the zinc finger 




Another genome-wide linkage scan was performed in PCD families from 
two different isolated populations: from the Faroe Islands and from the Druze 
community in northern Israel. Subsequent fine mapping pointed to two PCD-
linked loci, located on chromosomes 16p12.1-12.2 and 15q13.1-15.1 in the Faroe 
Islands and the Israeli Druze population, respectively. The Faroe Island subset 
consisted of families with the absence of outer dynein arms; only one patient 
exhibited situs inversus. In the Druze families, several patients exhibited situs 
inversus and a partial loss of inner dynein arms.
93
 
A genome-wide linkage search performed in 31 PCD families failed to 
identify the major disease locus, confirming the common conviction on extensive 
locus heterogeneity.
94
 Potential genomic regions harboring PCD loci were localized 
on chromosomes: 3p, 4q, 5p, 7p, 8q, 10p, 11q, 13q, 15q, 16p, 17q and 19q. Linkage 
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analyses in PCD families with a documented dynein arm deficiency provided 
suggestive evidence for a linkage to chromosomal regions 8q and 16pter, while 
analyses carried out exclusively in the Kartagener syndrome families pointed 
towards 8q and 19q as possible locations of the KS locus. 
 
Conclusions 
It is clear that PCD is genetically heterogeneous, with different genes involved in 
different families, depending, in part, on whether situs inversus is present (i.e., KS 
versus CDO subtypes of PCD). The results obtained so far confirm that PCD is not 
likely to be caused by mutations of hundreds of different genes, even though cilia 
themselves have so many structural, assembly and regulatory proteins. Future 
priorities are to identify the genes that reside in the mapped regions, and to 
identify new genes by combinations of linkage and linkage disequilibrium gene 
mapping strategies and by mutation screening of appropriate candidate genes. 
On the other hand, PCD is not the only disease where defects of the ciliary 
structure and function may be involved. PKD and RP may serve as examples. 
Although clinical features of those disorders are different and concern different 
organs, in some patients a PCD-related phenotype is also present, as in case of RP 
with bronchopulmonary symptoms or PKD with situs inversus. It is not known 
whether and how the genes mutated in those diseases affect ciliary function(s); one 
possibility could be that the tissue specific expression of some genes at different 
stages of ontogenesis results in tissue specific effects of their mutations, leading to 
clinical manifestations as different disorders. 
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III. Update of  the article “Primary ciliary dyskinesia: 
genes, candidate genes and chromosomal regions” 
Since the introductory article has been written, several developments in PCD 
genetics and biology of cilia occurred.  
Several approaches have been taken to characterize the ciliary genome and 
proteome. Liquid chromatography-mass spectrometry of human epithelial cilia 
identified 164 axonemal proteins.
1
 A mass spectrometry study of flagella of the 
unicellular alga Chlamydomonas reinhardtii identified 360 proteins very likely to be 
involved in cilia formation, and 292 that are probably involved.
2
 In addition, while 
comparing the genomes of non-ciliated organisms to ciliated ones, 688 and 183 
cilia-related genes in Chlamydomonas reinhardtii
3
 and in Drosophila melanogaster,
4
 
respectively, has been predicted. The presence of X-box promoter elements, which 
are targets of cilia-related transcription factors, has led to the identification of 
additional ciliary genes in Caenorhabditis elegans.
5, 6
 The results of these different 
studies have been assembled in online databases: the Ciliome database
7
 and the Cilia 
Proteome database.
8
 The cilium seems to be a far more complicated organelle than it 
was previously assumed. Thousands of proteins are involved in its functioning. 
Moreover, the classical division into motile cilia and the sensory primary cilia is 
blurred since motile cilia perform a variety of mechanosensory or chemosensory 
functions and primary cilia located on the embryonic node are motile.
9, 10
 
In the recent years several new disease causing genes have been described. 
TXNDC3 encodes a thioredoxin–nucleoside diphosphate kinase, a member of  a 
large family of enzymatic proteins that function as general protein disulfide 
reductases. TXNDC3 protein is the human ortholog of the sea urchin IC1 gene 
encoding a component of sperm outer dynein arms. Duriez and colleagues screened 
for mutations in TXNDC3 in forty seven PCD patients and identified a heterozygous 
T>A transversion in exon 15, causing a nonsense mutation at codon 426 
(c.1277T>A, p.Leu426X) in one individual.
11
 A heterozygous C>T transition in 
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intron 6 (c.271–27C>T) turned out to be the second disease causing allele. The 
transition is present in 1% of control population. This SNP modifies the ratio of two 
physiological isoforms generated by alternative splicing of TXNDC3. So far this 
patient represents the only case of PCD associated with mutations in TXNDC3. 
A whole-genome linkage scan in a consanguineous Iranian Jewish kindred 
by use of single nucleotide polymorphisms arrays detected linkage to chromosome 
17q25.1. A region of homozygosity shared between the four affected offspring was 
identified across the DNAI2 gene. Sequencing of DNAI2 exons revealed a mutation 
affecting the donor splice site of exon 11. A subsequent mutation screen in 105 
unrelated PCD families revealed two families with disease causing mutations in 
DNAI2. Some of these patients displayed situs inversus and the ultrastructural 
imaging of cilia showed outer dynein arms defects.
12
 
 Castleman and colleagues performed a linkage study in seven 
consanguineous families with PCD and central-microtubular-pair abnormalities. One 
locus on chromosome 6p21.1 was identified in two families with intermittent 
absence of the central-pair structure in electron microscopy of cilia. Candidate genes 
sequencing revealed mutations in RSPH9. Another locus was mapped on 
chromosome 6q22.1 in five families with complete absence of the central pair in 
electron microscopy of cilia. Mutations were subsequently identified in RSPH4A. 
Both RSPH9 and RSPH4A encode proteins, which on the basis of homology with 
proteins of the biflagellate alga Chlamydomonas reinhardtii, are predicted to be 




A Japanese rice fish called Medaka (Oryzias latipes), when having a 
mutation in the Ktu gene develop laterality defects, polycystic kidney disease, and 
have impaired sperm motility. Cilia and flagella from the mutant fish show defects 
or loss of outer and inner dynein arms. Ktu/PF13 protein is involved in pre-assembly 
of dynein arm complexes in the cytoplasm. A mutation screen of the Ktu gene in 112 
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PCD pedigrees detected two homozygous mutations in two consanguineous 
families. In both families situs inversus has been observed.
14
 
 Two groups independently reported mutations in LRCC50, coding for 
another protein involved in pre-assembly of dynein arms in the cytoplasm. 
Duquesnoy and colleagues followed a candidate-gene approach based on data from a 
mutant strain of Chlamydomonas reinhardtii carrying an ODA7 defect. Mutations in 
human orthologoue of ODA7, the LRCC50 gene, were found in four families with a 
PCD phenotype, characterized in a ciliary ultrastructure by the absence of both 
dynein arms. Situs inversus was present in three patients.
15
 Loges and colleagues 
performed total-genome scans by using single-nucleotide polymorphism (SNP) 
arrays in seven consanguineous PCD families with combined ODA and IDA defects. 
In one of these families they found four regions with homozygosity by descent and 
the highest LOD score. By analysis of candidate genes mutations in LRCC50 were 
detected including one large deletion.
16
 
The highly inbred structure of the Old English Sheepdog population allowed 
identification of mutations in ccdc39 gene in dogs suffering from chronic airway 
inflammation. Sequencing of the human ortholog revealed loss-of-function 
mutations in 19 out of 50 selected families with absence of inner dynein arms 




 Mouse and zebrafish ccdc40 mutants display laterality and cilia defects. 
Sequencing analysis of CCDC40 in a cohort of 26 PCD families revealed mutations 
in 17 patients from 15 families. The electron microscopy of cilia showed 
misplacement of central pair microtubules and defects in several axonemal 
structures excluding outer dynein arms.
18
 
Orofaciodigital syndrome type I (OFD1) is an X-linked dominant disease 
characterized by malformations of the face, oral cavity, and digits. Mutations in 
OFD1, encoding a protein localized at the centrosome and basal body of primary 
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cilia, cause orofaciodigital syndrome. A frameshift mutation in OFD1 was found in 
an extended family in which X-linked intellectual disability cosegregated with PCD. 




 Homozygosity mapping and subsequent sequencing analysis performed in 
two consanguineous Bedouin families identified mutation in DNAL1 encoding the 
ortholog of the Chlamydomonas axonemal dynein light chain 1. All the three 




Ciliopathies are an emerging group of pleiotropic, clinically overlapping human 
disorders caused by mutations in ciliary genes.
21
 Primary ciliary dyskinesia involves 
the dysfunction of motile cilia. The remaining ciliopathies are caused by mutations 
in genes important for functioning of primary cilia, however in some of these 
diseases motile cilia can also be affected. The spectrum of clinical symptoms of 
ciliopathies is broad and the genetic heterogeneity of these diseases is high.  
Autosomal dominant polycystic kidney disease (ADPKD) is caused by 
mutations in PKD1 and PKD2 genes, which encode polycystin 1 and polycystin 2 
respectively.
22
 ADPKD causes chronic renal failure in adults. It was the first disease 
linked to sensory cilia dysfunction. Primary cilia in renal tubules detect flow by 
bending and transmit a calcium-mediated signal to epithelial cells. 
Mutations in more than a dozen genes can cause nephronophthisis, an 
autosomal recessive kidney disease leading to renal failure.
23
 Some patients present 
with extrarenal symptoms: retinal degeneration (Senior-Loken syndrome), mental 
retardation, cerebellar ataxia, bone anomalies or liver involvement.  
Bardet-Biedl syndrome (BBS) is a rare, genetically heterogeneous, 
autosomal recessive ciliopathy with a varied clinical presentation, including retinal 
degeneration, polycystic kidneys, truncal obesity, polydactyly, hypogonadism, 
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intellectual disability, diabetes mellitus, and congenital heart disease. There are at 
least 12 BBS genes encoding proteins of the basal bodies and the axonemes. 
Meckel-Gruber syndrome (MKS) is a fatal ciliopathy, characterized by 
cystic renal disease, polydactyly, hepatic developmental defects, pulmonary 
hypoplasia, posterior encephalocele, and other central nervous system 
abnormalities.
24
 Mutations in six genes have been found in MKS families.  
Joubert syndrome is characterized by distinctive cerebellar and brain stem 
malformation called the molar tooth sign, hypotonia, and developmental delays. This 
phenotype can be accompanied by retinal degeneration, renal disease, occipital 
encephalocele, hepatic fibrosis, and polydactyly.
25
 To date, mutations in 14 genes 
have been identified in individuals with a Joubert syndrome and related disorders. 
 Orofaciodigital syndrome type 1 is an X-linked dominant disorder caused 
by mutations in the OFD1 gene encoding a centrosomal protein.
26
 The disease is 
lethal in males. Females with OFD1 mutations present with oral, dental, facial, and 
digital anomalies. Affected individuals can also have renal cysts and CNS 
abnormalities. 
There is a significant genetic and clinical overlap between ciliopathies. For 
example, Meckel-Gruber syndrome and nephronophthisis can be caused by 
mutations in NPHP1. The CEP290 gene encodes a centrosomal protein involved in 
ciliary assembly and ciliary trafficking. Mutations in CEP290 have been found in 
Bardet-Biedl syndrome, Joubert syndrome, Leber congenital amaurosis, Meckel-
Gruber syndrome, and Senior-Loken syndrome.
27
 Situs inversus can be present in 
patients with PCD, nephronophthisis, Bardet-Biedl syndrome and Joubert syndrome. 
Biliary atresia is a neonatal disorder characterized by fibroinflammatory obliteration 
of the biliary tract. Approximately 20% of the patients have left-right laterality 
defects and abnormalities of cholangiocyte cilia.
28
 The PCD phenotype can be 
associated with biliary atresia.
29
 Retinal degeneration is a common feature of several 
ciliopathies related to primary cilia. Mutations in the retinitis pigmentosa GTPase 
regulator gene (RPGR) have been found in patients presenting with retinal 
46 
 
degeneration and the primary ciliary dyskinesia phenotype.
30
 A syndrome 
characterized by respiratory features consistent with PCD,  intellectual disabilities, 
and  macrocephaly can be caused by mutation in OFD1, providing another example 
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Background: Primary ciliary dyskinesia (PCD) is a genetic disorder caused by 
ciliary immotility/dysmotility due to ultrastructural defects of the cilia. Kartagener 
syndrome (KS), a subtype of PCD, is characterised by situs inversus accompanying 
the typical PCD symptoms of bronchiectasis and chronic sinusitis. In most cases, 
PCD is transmitted as an autosomal recessive trait, but its genetic basis is unclear 
due to extensive genetic heterogeneity.  
Methods: In a genome-wide search for PCD loci performed in 52 KS families and 
in 18 PCD families with no situs inversus present (CDO, ciliary dysfunction-only), 
the maximal pairwise LOD score of 3.36 with D15S205 in the KS families indicated 
linkage of a KS locus to the long arm of chromosome 15. In the follow-up study, 65 
additional microsatellite markers encompassing D15S205 were analysed.  
Results: A maximal pairwise LOD score of 4.34 was observed with D15S154, 
further supporting linkage of the KS, but not the CDO, families to 15q24–25. 
Analysis of heterogeneity and haplotypes suggested linkage to this region in 60% of 
KS families.  
Conclusions: Reinforced by the results of multipoint linkage, our analyses indicate 
that a major KS locus is localised within a 3.5 cM region on 15q, between D15S973 
and D15S1037.  
Introduction 
Primary ciliary dyskinesia (PCD), formerly known as immotile cilia syndrome 
(MIM 244400; 242650), is a systemic disease caused by inherited dysfunction of the 
ciliary apparatus.
1,2
 Analogous to mitochondrial, lysosomal, and peroxisomal 
diseases, PCD therefore belongs to a group of disorders involving cellular 
organelles.
3
 The clinical consequences of PCD cover a wide spectrum and mainly 
affect the lower and upper airways and the male reproductive system. In general, 
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prognosis remains good, but morbidity can be considerable if the disease is not 
correctly managed.
4
 All forms of PCD are characterised by dysmotility or immotility 
of cilia in airway epithelial cells, spermatozoa, and other ciliated cells of the body.
3, 
5, 6 
Estimates of PCD incidence range from 1/16 000 to 1/60 000 live births.
5
 
Half of all PCD cases are classified as Kartagener syndrome (KS, 1/32 000 and 
1/120 000 live births), where bronchiectasis and chronic sinusitis are also 
accompanied by situs inversus (SI), a reversal of the usual left-right asymmetry of 
the abdominal and thoracic organ locations.  
All forms of PCD are characterised by dysmotility or immotility of cilia in 
airway epithelial cells, spermatozoa, and other ciliated cells of the body.
3, 5, 6 The 
cases of ciliary dysmotility or immotility reported to date are associated with 
ultrastructural defects of the cilia, such as a total or partial absence of dynein arms 
(70–80% of all electron microscopy detectable defects), defects of radial spokes or 
nexin links, and general axonemal disorganisation with microtubular transposition.
5
 
Discoordination of ciliary function can also be caused by random orientation of the 
cilia.
7
 Inheritance of PCD in most families is autosomal recessive, although 
pedigrees showing autosomal dominant or X-linked modes of inheritance have also 
been reported.
8–10
 Although within families PCD appears to be transmitted via a 
single locus, a broad spectrum of ciliary ultrastructural defects clearly suggests that 
PCD is genetically heterogeneous.  
The molecular basis of PCD is far from being clear. Up to 250 different 
polypeptides have been identified within the ciliary axoneme of the model 
unicellular alga Chlamydomonas reinhardtii; at least the same number of proteins 
can be expected in the axonemes of humans.
11
 It is rather unlikely that mutations 
within as many as 250 different genes coding for various ciliary proteins cause the 
same or similar pathologic consequences of ciliary dysfunction. If this were true, 
one might expect the incidence of PCD to be much higher than it actually is.
3
 It is 
possible that mutations in some ciliary protein gene(s) may be lethal even if 
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heterozygous, while mutations in other genes may not affect ciliary function at all. 
Hence, one would expect involvement of a limited number of genes in the 
pathogenesis of this disorder. This potential reduction of locus heterogeneity 
provides cautious optimism for the success of gene mapping efforts.  
So far, only two known human genes, DNAI1 and DNAH5, have a 
documented causative effect in PCD. DNAI1, located in 9p13–21, codes for the 
intermediate chain of the axonemal dynein and is an ortholog of the IC78 dynein 
gene in Chlamydomonas.
12–14
DNAH5, located in 5p15–p14, codes for the heavy 
chain of the axonemal dynein and is related to the Chlamydomonas gene coding for 
the dynein γ-heavy chain.15 Mutations in both these genes cause an outer dynein 
arms defect phenotype. The relatively broad spectrum of low frequency mutations in 
both these genes enhances the genetic heterogeneity of PCD. Together, mutations in 
DNAI1 and DNAH5 have been shown to account for ~24% of PCD.
16  
Obviously, mutations in genes other than DNAI1 and DNAH5 must be 
responsible for most PCD.  
In the past, a number of genome-wide scans in PCD families have been 
performed, resulting in several chromosomal regions being considered as candidates 
for PCD gene(s) locations. A genome-wide, low density linkage search performed in 
31 PCD families revealed potential PCD loci on 3p, 4q, 5p, 7p, 8q, 10p, 11q, 13q, 
15q, 16p, 17q, and 19q, but failed to identify a major disease locus, confirming 
extensive locus heterogeneity.
17
 A genome scan in five PCD families of Arabic 
origin (four with reported consanguinity) indicated a possible PCD locus on 
19q13.3.
18
 Another genome-wide scan and subsequent fine mapping in Faroe Island 
and Israeli Druze families pointed to two PCD linked loci, on 16p12.1–12.2 and 
15q13.1–15.1, respectively.19 
In our previous study on Polish PCD families, linkage analysis performed 
separately in families with KS and families with CDO (ciliary dysfunction-only, that 
is PCD not accompanied by situs inversus), indicated that these two subtypes of the 
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disorder are caused by genes located in different genomic regions.
20
 We excluded 
linkage of a KS locus to chromosome 7,
20
 contrary to the suggestion of other 
authors.
21
 At the same time, however, our results provided suggestive evidence of 
linkage to 7p15 in the non-KS subset of Polish PCD families. Subsequently, 
DNAH11, the gene for the axonemal dynein heavy chain, has been mapped to the 
7p15 region,
22
 but its involvement in the pathogenesis of PCD remains unclear.  
Here we report the chromosomal localisation of a putative KS locus based 
on linkage analysis in Polish PCD families. The results of both pairwise and 
multipoint analyses suggest that ~60% of the KS families are linked to a 3.5 cM 
region on 15q24–25. In contrast, the CDO families are excluded from linkage to 
chromosome 15, thus demonstrating locus heterogeneity for PCD in general. 
Methods 
We recruited a total of 70 PCD families, 66 from Poland and four from Slovakia. 
The families studied in this report did not come from a genetic isolate. Each family 
had at least one member diagnosed as having PCD with no other major anomalies or 
dysmorphologies present. In 60% of the families, the clinical diagnosis was 
confirmed by transmission electron microscopy (EM) analysis of bronchial cilia 
ultrastructure; of 46 PCD patients analysed by EM, 32 displayed outer and inner 
dynein arms defects, 11 outer dynein arms defects, and three inner dynein arms 
defects.  
Families were classified as KS if at least one PCD affected member 
exhibited situs inversus (52 families), or as CDO if none of the affected members 
exhibited situs inversus (18 families). The mode of inheritance in all families studied 
was consistent with autosomal recessive transmission (that is, both sexes affected at 
comparable frequencies, no affected parents or distant relatives). In the KS families, 
60 affected subjects (including eight independent pairs of affected siblings and one 
affected trio) and 139 unaffected family members were genotyped. One KS family 
with a consanguinity loop, initially included in the study group, was excluded from 
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further calculations after haplotype analysis. In the CDO families, 21 affected 
subjects (including three independent pairs of affected siblings) and 39 unaffected 
members were analysed.  
A whole genome scan with 462 microsatellite markers (11–32 per 
chromosome) was performed. Markers were distributed with a mean intermarker 
distance of ~8 cM. There were nine intervals between adjacent markers greater than 
20 cM; the three largest intermarker intervals were 35, 26, and 26 cM. In the 
extended analysis of chromosome 15q, 62 marker loci encompassing D15S205 were 
added, with a mean heterozygosity of 0.7 and intermarker distances of 0–2 cM. 
Markers were assigned genetic map positions using the Decode map.
23
 For markers 
positioned at exactly the same location or not included in the Decode genetic map,
23
 
the latest Ensembl assembly (v27.35a.1) was used to determine marker order and to 
estimate genetic map distances for multipoint linkage analyses.  
All PCR amplified microsatellite markers were genotyped using 
fluorescence based, semi-automated DNA sizing technology,
24
 based on Applied 
Biosystems 373 Automated DNA Sequencers and GENESCAN and GENOTYPER 
software (Applied Biosystems, Perkin Elmer, Foster City, CA).  
Pairwise LOD score analyses were performed using FASTLINK.
25
 
Multipoint LOD scores allowing for locus heterogeneity were calculated using 
HOMOG on data generated by LINKMAP.
26
 Multipoint LOD scores for markers on 
chromosome 15 were calculated using GENEHUNTER.
27
 We assumed a recessive 
mode of inheritance with full penetrance, 0.0001 phenocopies, and a PCD disease 
allele frequency of 0.005.
20
 These assumptions were designed to yield a population 
prevalence for the disease consistent with that reported for PCD. A model with no 
phenocopies was used to determine heterogeneity in the analysed KS families. 





To assess the statistical power of our collection of PCD families, we calculated the 
maximum pairwise LOD score for a theoretical marker locus with nine alleles and a 
heterozygosity of 0.73, linked at different θ’s to the disease locus. The results 
indicated that linkage would be detected resulting in a LOD score >3.3 (at θ = 0 and 
assuming locus homogeneity) with both the entire collection of 70 PCD families and 
with the subset of 52 KS families, but not with the 18 CDO families (the expected 
maximal LOD score in the CDO subset was below the value of 2, reflecting the low 
power of detecting linkage in those families). 
A genome-wide scan was performed with 462 microsatellite markers. In the 
52 KS families, one single marker locus on the long arm of chromosome 15 
(D15S205) revealed a LOD score >2; the maximal LOD score value for D15S205 
was 3.36, at θ = 0.05. As expected, none of the markers showed pairwise LOD scores 
>2 in the set of 18 CDO families; combining both subsets (that is, the KS and CDO 
families) resulted in pairwise LOD scores below the level of statistical significance. 
This preliminary analysis was followed by typing the 52 KS families with 62 
additional microsatellite markers spanning ~20 cM surrounding D15S205, roughly 
corresponding to 21 Mb of the total physical distance. The highest pairwise LOD 
score value of 4.34 (at θ = 0) was obtained for D15S154 located on 15q24–25 (Table 
1). 
To examine whether all the analysed KS families were likely to be linked to 
this chromosome 15q region, we performed tests of heterogeneity (HOMOG 
software). The test results supported heterogeneity (H2: linkage, heterogeneity v H1: 
linkage, homogeneity; likelihood ratio 487.33) indicating that chromosome 15q is 
likely to be involved in 60% of the KS families. Six pedigrees out of 52 were 
indicated as being unlinked to the region. Analysis of haplotypes (not shown) 
revealed that in four of those pedigrees affected and unaffected siblings shared both 
parental haplotypes, while in two other pedigrees affected siblings had different 
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parental haplotypes. Another 15 pedigrees were not informative and were eliminated 
from further calculations. Analysis of the remaining 31 pedigrees confirmed linkage 
under homogeneity (H1: linkage, homogeneity v H0: no linkage; likelihood ratio 
8.511×106).  
 
Table 1.  Pairwise linkage findings for the high density follow up on chromosome 












D15S967 75.67 0.702202 0.15 1.546949 0.1 
D15S131 76.52 0.720699 0.1 2.470191 0.05 
D15S204 77.60 1.466857 0.05 2.880023 0.05 
D15S197 77.69 0.851782 0 2.018382 0 
D15S124 78.37 0.278873 0.15 1.658671 0.05 
D15S192 78.38 1.036385 0.1 2.333415 0.05 
D15S818 79.03 1.016548 0.1 2.980691 0.05 
D15S984 80.37 2.860638 0.05 3.80305 0.05 
D15S989 83.75 0.445265 0.15 2.075293 0 
D15S1005 84.19 2.339443 0.05 5.758866 0 
D15S969 84.31 1.373751 0.05 3.693551 0 
D15S1037 85.81 2.860638 0.05 3.80305 0.05 
D15S1047 85.83 1.180228 0.05 2.358563 0.05 
D15S211 85.84 2.248682 0.05 3.033275 0.05 
D15S206 87.02 2.35253 0 2.024841 0.05 
D15S115 87.24 3.641433 0 2.124683 0.1 
D15S205 89.09 3.364761 0.05 4.176748 0.05 
D15S154 89.10 4.344967 0 2.636754 0.05 
D15S653 89.22 1.681151 0.05 1.591634 0.1 
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D15S539 89.22 1.651598 0.05 2.47482 0.05 
D15S152 89.30 3.506446 0 2.372452 0.1 
D15S972 89.31 2.727519 0.05 3.466998 0 
D15S999 89.30 1.290613 0.05 2.626094 0.05 
D15S979 93.21 2.15897 0.05 2.175463 0.1 
D15S1045 94.83 2.358117 0 2.914872 0 
D15S116 95.49 2.829704 0.05 2.067284 0.1 
D15S127 97.26 0.775935 0.1 1.525221 0.1 
 
a
Only markers with LOD>1.5 are shown; 
b 
Calculated in 52 KS families; 
c 
Calculated in 31 KS families (without the 6 unlinked and 15 uninformative 
families).  
Results of the pairwise LOD scores obtained for the 31 KS families 
“homogenised” for their linkage to 15q are shown in Table 1. The highest pairwise 
LOD score value (5.75) was obtained for D15S1005. The result of the multipoint 
linkage analysis performed on the homogenised set of 31 KS families (Figure 1) 
confirmed the pairwise LOD score results and excluded close linkage of more 
distantly located marker loci with KS. The multipoint LOD scores reduced abruptly 
at the genetic map positions 80.8 and 87.2 cM (at markers D15S991 and D15S115, 
respectively). The 95% confidence interval (LODmax−1) localised the putative KS 
gene to a 3.5 cM region between D15S973 and D15S1037.  
Interestingly, no extended common haplotype encompassing marker 
D15S1005 could be detected among the affected members of different KS 
families (Figure 2). Two longest common haplotypes, one encompassing 
three markers to the left and two right of D15S1005, and another 
encompassing five markers to the right of D15S1005, were shared by only 
two families each. Even if only three markers including D15S1005 were 
considered, a common haplotype was shared by at most four families. This 
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contradicts the notion of the ancestral haplotype carrying the major common 
mutation.  
 
Figure 1. The multipoint LOD score plot for  31 KS families. Disease gene 
frequency 0.005; penetrance 1.0; phenocopies 0.0 
 
Both pairwise and multipoint LOD scores calculated for the set of 18 CDO 
families were negative for the entire KS region, excluding close linkage of this 
region to PCD without situs inversus. Even when genetic heterogeneity within the 
CDO subgroup of PCD was assumed, allowing only some of the families to be 
linked to this region, the maximum pairwise LOD scores for all markers in this 




Figure 2. Segregation of haplotypes in six selected families, thus narrowing  




In our previous study on Polish PCD families, we excluded linkage of a KS locus to 
chromosome 7,
20
 contrary to the suggestion of other authors.
21
 At the same time, 
however, our results provided suggestive evidence of linkage to 7p15 in the subset 
of PCD families without situs inversus. Our disparate results for linkage of PCD to 
chromosome 7 in the KS and CDO families
11
 indicated that the genetic basis of these 
two forms of PCD might be different, consistent with some postulated animal 
models such as the hop mouse mutation, which exhibits CDO without situs 
inversus.
28
 In a search for putative PCD genes on other candidate chromosome(s), 
we examined our collection of PCD families after splitting them into subsets of KS 
and CDO families. Both the genome scan and the follow-up linkage analyses 
confirmed linkage to chromosome 15q in the KS but not in the CDO families. 
Importantly, when both subsets of PCD families, that is, the KS and CDO families, 
were combined, the pairwise LOD scores for the markers that were significant in the 
KS families, dropped below the level of statistical significance. This indicated that 
the failure to find linkage in CDO families, rather than merely reflecting the low 
number of families, revealed the real lack of linkage of the analysed chromosome 15 
region to CDO. These gene mapping findings are consistent with the hypothesis that 
there is no single gene of major effect that controls the risk for both forms of PCD. 
Had such a gene existed, the combined set of the KS and CDO families would have 
yielded stronger support for the linkage.  
Linkage analysis in genetically heterogeneous recessive disorders presents a 
difficult task. Large pedigrees with many affected persons are rare and heterogeneity 
obscures the linkage signal by introducing noise from unlinked families. We have 
successfully applied a strategy that was used in mapping Bardet-Biedl syndrome, a 
heterogeneous recessive disorder with eight loci reported so far.
29, 30 Once the 
threshold of LOD score value showing significant linkage to chromosome 15q was 
reached and confirmed in the follow up analysis with more markers, we focused our 
efforts on homogenising the analysed set of KS families. Statistical analysis of 
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heterogeneity, performed under a more stringent disease model with full penetrance 
and no phenocopies, indicated six families with negative LOD scores in the 
D15S1005 region. Excluding those families resulted in the increased LOD scores for 
D15S1005 and its closest neighbours and enabled us to narrow the region containing 
the putative KS gene. As can be seen in Table 1, by removing the unlinked families 
we eliminated noise from our data: LOD scores maximise at θ = 0 for the immediate 
neighbours of D15S1005 and at θ = 0.05 for the more distant markers within 10 cM.  
Another genome-wide scan and subsequent fine mapping in Israeli Druze 
PCD families pointed to a PCD locus at 15q13.1–15.1.19 Although in Druze families 
several patients exhibited situs inversus and partial loss of inner dynein arms, the 
15q region implicated in KS is located proximally from the region identified in this 
study.  
The physical size of the KS candidate region defined by the physical map 
position of the markers D15S973 and D15S1037 is ~2.8 Mb. This candidate region 
contains 35 genes and coding sequences, but no known functional candidate genes 
with a clear involvement in the ciliary structure and/or relevant to KS pathogenesis 
were identified among them. However, a number of interesting candidates reside in 
this region. The gene coding for the cellular retinoic acid binding protein 1 
(CRABP1), located at 15q24, is one of the potential candidates. Retinoic acid is an 
important factor during development of the organism.
31
 It is involved in promoting 
development of ciliated cells in lungs,
32
 and also plays a role in spermatogenesis; 
moreover, changes in its concentration in the murine embryo may lead to situs 
aberrations.
33
 Other potential candidates include the MESDC1 and MESDC2 
(mesodermal development candidates 1 and 2) genes located at 15q25: MESDC1 
might be involved in anterior-posterior axis development in mouse.
34
 The potential 
role of these genes in the pathogenesis of KS remains to be elucidated.  
In conclusion, our linkage analysis confirms the concept of locus 
heterogeneity in the pathogenesis of PCD, at least when its different forms – with 
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and without situs inversion – are considered. Most likely localisation of the 
purported KS locus is within the 3.5 cM region on 15q24–q25. 
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Primary ciliary dyskinesia (PCD) is a rare genetic disorder, which shows extensive 
genetic heterogeneity and is mostly inherited in an autosomal recessive fashion. 
There are four genes with a proven pathogenetic role in PCD. DNAH5 and DNAI1 
are involved in 28 and 10% of PCD cases, respectively, while two other genes, 
DNAH11 and TXNDC3, have been identified as causal in one PCD family each. We 
have previously identified a 3.5 cM (2.82 Mb) region on chromosome 15q linked to 
Kartagener syndrome (KS), a subtype of PCD characterized by the randomization of 
body organ positioning. We have now refined the KS candidate region to a 1.8 Mb 
segment containing 18 known genes. The coding regions of these genes and three 
neighboring genes were subjected to sequence analysis in seven KS probands, and 
we were able to identify 60 single nucleotide sequence variants, 35 of which resided 
in mRNA coding sequences. However, none of the variations alone could explain 
the occurrence of the disease in these patients. 
Introduction 
Primary ciliary dyskinesia (PCD, MIM no. 242650) is a rare genetic disorder caused 
– as far as is known – by mutations in genes encoding proteins important for ciliary 
beating.
1
 The major clinical consequences fall into three categories: (1) in the 
respiratory tract, immotility or dyskinetic beating of cilia in epithelial cells impairs 
the mucociliary clearance, leading to recurrent infections, sinusitis and 
bronchiectasis; (2) in the urogenital tract, infertility occurs in some patients because 
of the dysmotility of sperm tails; (3) mirror reversal of body organ positioning (situs 
inversus) is seen in approximately half of PCD patients. It is believed to occur at 
random and to be caused by the immotility of primary cilia of cells on the ventral 
surface of the embryonic node. The presence of situs inversus in an affected family 
defines a PCD subtype, known as Kartagener syndrome (KS, MIM no. 244400). 
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For diagnostic purposes, cilia in bronchial scrapings can be visualized under 
a light microscope, whereas the clinical diagnosis of PCD is routinely verified by 
electron microscopy analysis of respiratory cilia ultrastructure. About 20 different 
ultrastructural defects have been described in PCD patients, with lesions of outer 
and/or inner dynein arms being the most frequent defects of the internal anatomy of 
cilia.
2, 3
 Recently, it has been shown that immunofluorescence staining of ciliated 
epithelium with antibodies targeting DNAH5 can detect outer dynein arms defects 
and therefore aid diagnosis of PCD.
4
 
Inheritance of PCD is autosomal recessive in most cases, although pedigrees 
with an X-linked mode of inheritance have also been described.
5, 6
 To date, 
mutations in four genes have been found as causative for PCD, exclusively in 
patients with outer dynein arm defects. DNAI1, coding for intermediate dynein chain 
1, was selected for mutation screening based on homology with the Chlamydomonas 
reinhardtii gene, which causes a slow-swimming phenotype when mutated,
7, 8
 
whereas DNAH5, coding for heavy dynein chain 5, was identified by homozygosity 
mapping in a large family and subsequent sequence analysis.
9
 DNAH5 and DNAI1 
are responsible for 28 and 10% of PCD cases, respectively,
10, 11
 clearly indicating 
that other genes are involved in PCD/KS etiology. DNAH11,
12
 coding for dynein 
heavy chain, and TXNDC3,
13
 coding for a thioredoxin family member, were also 
found to be responsible for PCD, but so far each has been found in only one family. 
Analysis of the ciliary proteome in unicellular alga C. reinhardtii led to the 
identification of a number of proteins potentially involved in cilia formation and 
maintenance: 360 proteins with high and 293 with moderate confidence.
14
 Besides 
the known components of ciliary ultrastructure, there were also 90 signal 
transduction proteins, and many membrane proteins and metabolic enzymes. Given 
that our knowledge of ciliary genes comes mostly from studies of simple organisms 
and that the functional spectrum of the possible candidate genes is very wide, it is 
difficult to predict which of these should be considered as candidate genes for PCD. 
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On the basis of genetic linkage studies, extensive genetic heterogeneity of 
PCD is postulated. A total-genome scan performed in 31 multiplex families did not 
reveal any predominant locus, rather it showed several peaks with suggestive and 
indicative LOD scores.
15
 Another genome scan, performed in five families of Arabic 
origin and with reported consanguinity, revealed linkage with chromosome 19q13.3 
in only three of the families, thus confirming locus heterogeneity.
16
 Two additional 
loci, on 16p12 and 15q, were indicated by studies on genetically isolated, but 
heterogeneous, populations from the Faroe Islands and the Israeli Druze.
17
 
We earlier performed genome-wide linkage analysis in 52 families with KS 
and reported a region on chromosome 15q24–25, between D15S973 and D15S1037, 
linked to KS.
18
 After obtaining a significant LOD score of 4.34 with D15S154 
(using a strictly defined disease model), we defined a region of 3.5 cM (2.82 Mb) as 
containing the candidate gene.
18
 In the present study, we have performed further 
fine-mapping of the region of interest and screened all 18 genes in the linked region 
and three neighboring genes for mutations in seven KS patients from the families 
that contributed most to the linkage results.
18
 
Materials and methods 
Biological material 
DNA samples from the existing PCD collection
18
 came from 31 Caucasian families 
(25 of Polish and 6 of Slovak origin) classified as KS families; none was from a 
genetically isolated population. Each family had at least one member diagnosed with 
PCD and exhibiting situs inversus, but with no other major anomalies or 
dysmorphologies present. The group studied consisted of 38 affected individuals and 
99 unaffected family members. The primary complaints in these patients were 
derived from the respiratory tract and the clinical picture included symptoms of 
sinusitis, nasal polyps, bronchiectasis, recurrent infections of the upper respiratory 
tract. All cases were confirmed by a low concentration of nitric oxide (NO) 
measured in exhaled air.
19
 NO was measured from the nasal cavity by a 
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chemiluminescence analyzer with a threshold value of 200 ppb for diagnosing PCD. 
In 60% of the families, the clinical diagnosis was confirmed by transmission 
electron microscopy analysis of bronchial cilia ultrastructure; the analysis revealed 
defects of outer or outer and inner dynein arms; a representative EM picture is 
shown in Supplementary figure 1. Direct microscopy of bronchial scrapings was 
used to confirm the clinical diagnosis of PCD in the patients that did not have 
electron microscopy imaging of cilia. KS inheritance in these pedigrees was in 
agreement with general assumptions for an autosomal recessive disease model. KS 
in these families has previously been shown to be linked with the region between 
D15S973 and D15S1037, assuming full penetrance, 0.0001 phenocopies and the 
disease allele frequency of 0.005. The genome-wide significant LOD score of 4.34 
was obtained using a cohort of 52 families.
18
 Pair-wise LOD score analyses were 
performed using the FASTLINK program, and multipoint LOD scores for markers 
on chromosome 15 were calculated using GENEHUNTER. Multipoint LOD scores 
allowing for locus heterogeneity were calculated using Simwalk2. The 95% 
confidence interval localized the KS locus to a 3.5 cM region between D15S973 and 
D15S1037. 
Recombination mapping using microsatellite markers 
To refine the candidate gene region between D15S973 and D15S1037, seven 
markers (D15S1027–380 kb–D15S524–33 kb–AFMA085AWB9–580 kb–D15S989–
219 kb–D15S1005–58 kb–D15S969–695 kb–D15S551), were genotyped in all 38 
affected individuals and 99 unaffected family members. Amplification products, 
obtained using 5′ end fluorescent-dye-labeled primers, were pooled and analyzed on 
an automated ABI Prism 3730 DNA sequencer (Applied Biosystems, Foster City, 
CA, USA). Genotypes were scored using GENMAPPER (v3.5NT) software. 
Inheritance was checked using PEDCHECK
20
 and haplotypes in the 31 pedigrees 
were constructed from microsatellite data using SIMWALK2.
21
 
Analysis of candidate genes 
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Sequence analysis was performed in seven affected individuals from the families 
with the highest LOD score for marker D15S1005.
18
 Sequences of 135 exons and 
surrounding intron sequences of the 20 genes located in the region were obtained 
using Ensembl genome browser version 42 (Figure 1; Table 1). AL109678, not 
present in Ensembl, was also sequenced as it is an mRNA coding sequence 
annotated in the UCSC genome browser. At least 200 bp upstream of the 
transcription start site were also analyzed and the 3′UTR was sequenced in all genes 
except for TMC3, KIAA1199, ARNT2 and TMED3. The Primer3 program was used 
for designing PCR primers yielding products of 400–500 bp;22 primers were in the 
intronic sequences flanking the exons to be analyzed. PCR reactions were performed 
using standard protocols (data available upon request). Amplification products were 
purified, quantified on a 2% agarose gel, and diluted for direct sequencing on an 
automated ABI Prism 3730 DNA sequencer using BigDye Terminator Sequencing 
Standards (Applied Biosystems). Sequences were assembled using ContigExpress 
(Vector NTI suite v8.0, Informax Inc.). 
Sequencing reactions were performed first with the forward primer, but if 
the quality of the sequencing electropherogram was unsatisfactory, or if single-
nucleotide polymorphisms (SNPs) were found, they were repeated with the reverse 
primer. Each of the newly identified variants was validated through an independent 
PCR and sequencing reaction. The sequenced fragments were only included in the 
results if data were obtained for at least six of the seven patients. Seven reactions 
could not be amplified despite at least three attempts with two different sets of 
primers (nucleotides in mRNA sequence: BCL2A1, 602–710; FAM108C1, 1–343; 
C15ORF37, 421–640; TMED3, 260–299; ENSG00000180725, 457–618; FAH, 
683–783, 991–1037). Reactions failed to use control as well as patients' DNA, 
indicating PCR problems related to the local sequence composition of those genomic 
fragments. All variations found in the protein-coding sequence and not previously 
described in public databases were sequenced in a control population group 
consisting of 48 unrelated, healthy individuals of Polish origin. 
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Figure 1. The location of 21 genes in the linkage region on chromosome 15q24-25. 
The minimal KS gene-containing region is indicated by an arrow. 
Table 1. Genes included in the Kartagener syndrome sequencing study 




LOC390616 Unknown Unknown 1 1608 
AL109678 Unknown Unknown 1 2540 
TMED3 Transmembrane emp24 domain-
containing protein 3 precursor 
(Membrane protein p24B) 
protein transport; membrane; 
membrane; protein carrier 
activity 
3 1420 
K1024 UPF0258 protein KIAA1024 membrane; integral to membrane 4 6732 
MTHFS 5-formyltetrahydrofolate cyclo-




magnesium ion binding; folic 
acid binding; ligase activity; 
metabolism 
3 857 
ENSG00000205296 Unknown Unknown 2 153 
Q9HBF5 Cervical cancer suppressor-1 Unknown 2 240 
C15ORF37 C15orf37 protein Unknown 1 2082 
BCL2A1 Bcl-2-related protein A1 
(Protein BFL-1) (Hemopoietic-
specific early response protein) 
(Protein GRS) 


























ENSG00000180725 Unknown Unknown 2 698 
ZFAND6 Zinc finger A20 domain-
containing protein 3 (Associated 
with PRK1 protein) 
DNA binding; zinc ion binding; 
signal transduction; protein 
binding 
7 1680 
ENSG00000196548 Unknown Unknown 3 123 





magnesium ion binding; 






Aryl hydrocarbon receptor 
nuclear translocator 2 (ARNT 
protein 2) 
 
transcription factor activity; 
signal transducer activity; aryl 
hydrocarbon receptor nuclear 







Q8N817 CDNA FLJ40133 fis, clone 
TESTI2012231 
Unknown 4 675 
FAM108C1 Unknown Unknown 3 2326 
KIAA1199 KIAA1199 sensory perception of sound 29 6602 
MESDC2 Mesoderm development 
candidate 2 (NY-REN-61 
antigen) 
mesoderm development 5 2938 
MESDC1 Mesoderm development 
candidate 1 
Unknown 1 2373 
C15ORF26 Uncharacterized protein 
C15orf26 
Unknown 7 1574 
TMC3 Transmembrane channel-like 
protein 3 
integral to membrane 19 2443 
 
Results 
Seven microsatellite markers located in the 3.5 cM region reported to be linked to 
KS were genotyped in 31 families that had positive LOD scores for chromosome 
15q in our genome linkage scan
18
 (Figure 1). Haplotype analysis was concordant 
with linkage to chromosome 15q24–25 (data not shown). A recombination was 
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mapped in family numbers 114 and 126 (Figure 2), 1 Mb more telomerically from 
the previous location defined by marker D15S937, thus narrowing the minimal 
gene-containing region down to 1.8 Mb, between markers AFMA085AWB9 and 
D15S1037.  
The analysis of haplotype sharing between nonrelated KS patients was 
inconclusive. The most promising block, encompassing three markers (D15S524, 
AFMA085WB9 and D15S989) and spanning 0.6 Mb, was present on five 
nonrelated, affected chromosomes (families 103, 117, 136, 142 and 147) and on one 
untransmitted parental chromosome (data not shown). 
Seven families with the highest positive LOD scores were selected for 
sequence analysis of all the genes located in the 1.8 Mb region (Figure 2). These 
families contributed 70% of the LOD score for marker D15S1005 on chromosome 
15q,
18
 and it was interesting that the DNAI1 mutation analysis was negative in all 
seven families. The DNAH5 contribution was excluded in four families (114, 117, 
136 and 147; Figure 2), based on the analysis of SNPs located within the gene 
(discordant genotypes in the affected sibs), while in the three remaining families, the 
analyzed SNPs in DNAH5 were uninformative (unpublished data). As the 
microsatellite data confirmed linkage of the disease to 15q24–25 in all seven 
families, only one affected individual, representative of each pedigree, was subjected 
to DNA sequencing. Supplementary table 1 summarizes the clinical findings of the 
seven families included for sequencing. 
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Figure 2. Pedigrees of the KS families included in the sequencing. The results of the 
pair-wise LOD score for marker D15S1005 are indicated below each family. The 
recombination (marked by a red arrow) defining the minimal KS gene-containing 
region can be observed in pedigrees #114 and #126. Individuals included in the 
sequencing are indicated by black arrows. Red dots indicate individuals exhibiting 
situs inversus.  The numbers beside marker names indicate the intermarker distances 
in kilobase pairs. Missing data are denoted by zeros. The genotypes of the parents in 
pedigrees #117 and #126 were deduced from the genotypes of the siblings. 
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We analyzed the 18 coding sequences located between markers 
AFMA085WB9 and D15S1037 (Table 1). We also sequenced three genes located in 
the vicinity of the region, which could be functionally related to cilia: MESDC2, 
which is important in embryonic development; C15ORF26, which is expressed in 
lung and testis and displays homology to a flagellar protein identified in 
Chlamydomonas;
14
 and TMC3, a membrane protein with partial homology to 
nephrocystine, as indicated by Blast search of the NCBI nr database (Figure 1). 
Except for C15ORF26, none of the genes have been reported to be a part of cilium. 
In total, we analyzed 83 kb of genomic sequence in seven individuals (35 kb 
of coding sequences and 48 kb of intronic/flanking DNA). We found 60 SNPs, 45 of 
which were already present in public SNP databases. Twelve SNPs, including the 
four previously unknown ones, were located in the protein coding regions. None of 
the identified SNPs in the coding regions resulted in a stop codon change or a frame 
shift; six were amino-acid substitutions and seven were synonymous codon changes. 
Twenty-one SNPs, including seven novel ones, were located in the untranslated 
regions. Four SNPs were located in regions upstream of the transcription start site. 
Twenty-seven variations were located in noncoding regions, six of which were 
previously unknown. None of the SNPs found were closer than 10 bp to a splicing 
site. Variations in the protein-coding sequence, previously not described in SNP 
databases, were sequenced in 48 individuals of Polish origin to estimate population 
frequencies. Except for two SNPs (W399R in ARNT2 and A506G in AWP1), all the 
variations were found in the healthy controls. A complete list of the SNPs found is 
given in Table 2 and the distribution of all SNPs in the patients can be found in 
Supplementary table 2. 
Discussion 
We have performed a follow-up study to our previous finding
18
 of linkage to 
chromosome 15q24–25 in families with KS. Fine-mapping of the 3.5 cM (2.82 Mb) 
linked region in 31 KS families allowed us to narrow down the minimal candidate 
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gene region to 1.8 Mb. Analysis of haplotypes composed of microsatellite markers 
revealed that there was no extensive haplotype sharing among the affected 
individuals, arguing against the presence of only one or a few frequent mutations 
occurring on a common haplotype background. On the other hand, the absence of 
haplotype sharing does not exclude the possibility of the presence of a causative 
gene or genes in the linked region. The linkage analysis is independent of a founder 
effect. There are examples in literature of genes involved in rare recessive diseases, 
but not showing evidence of haplotype sharing. This happens because most of the 
patients are compound heterozygous for unique mutations in the given gene.
23
 
Table 2. List of all sequence variations found in 7 Kartagener syndrome patients. 











Number of patient chromosomes 
with the minor allele 
LOC39016 c.735C>T P245P exon 1 rs8038778 T=0.367  7/14 
TMED c.659G>A A172A exon 3 rs906439  A=0.0 0/14  
KIAA1024 c.847A>C N258Ha exon 2 -  C=0.06 2/14 
c.918C>A A281A exon 2 -   1/14 
c.2569A>G I832Vb exon 3 rs2297773 G=0.208  9/14 
c*1799A>C - 3'UTR rs17266017 C=0.375  2/14 
c.*3771_3772
insATG 
- 3'UTR -  Ins=0.06 2/14 
BCL2A1 c.238G>A C19Yc exon 1 rs1138357  A=0.146  3/14 
c.299T>G N39Kd exon 1 rs1138358 G=0.146  3/14 
MTHFS g.411A>G - Upstream rs2865825 -  1/14 
g.421C>G - Upstream rs2903105 -  3/14 
g.483delG - Upstream rs35401897 -  2/14 
C15ORF37 c.903C>A P166Qf exon 1 rs3803540 A=0.217  1/14 
c.*46G>T - 3'UTR rs17214656 T=0.167  2/14 
c.*124A>C - 3'UTR rs36070199 -  2/14 
c.*206A>G - 3'UTR rs12442408 G=0.250  1/14 
c.*413A>T - 3'UTR rs2733101 T=0.283  2/14 
AWP1 c.295-90T>C - intron 2 rs1916048 C=0.217  5/12 
C574+11C>G - intron 5 rs1522636 G=0.261  9/14 
c.466-60A>T - intron 4 rs12915043 -  1/14 
c.506A>G Q65Q exon 4 -  G=0.0  1/14 
FAH c.915-173delC - intron 10 rs3835063 -  6/14 
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c.1133C>T S352S exon 13 rs1801374 T=0.058  2/14 
c.1038-
35A>C 
- intron 12 rs2043691 C=0.08  1/14 
c.1038-
223C>T 
- intron 12 rs2043692 T=0.15  1/14 
c.*37A>C - 3'UTR rs1049181 -  2/14 
c.*38C>T - 3'UTR - -  2/14 
c.*39C>T - 3'UTR rs3210172 -  2/14 
c.*40C>T - 3'UTR - -  2/14 
c.*41C>G - 3'UTR - -  2/14 
c.*50delC - 3'UTR - -  2/14 
c. *93T>C - 3'UTR rs1049194 -  2/14 
ARNT2 c.312+15C>T - intron 3 rs2278708 T=0.058  1/14 
c.361-28insC - intron 3 rs5814026  -  3/14 
C574+36C>G - intron 4 rs8033507 G=0.017  1/14 
c.892-74C>T - intron 7 rs11072922  T=0.175  2/14 
c.1255+21C>
T 
- intron 11 rs3924894 T=0.405  8/14 
c.1255+22T>
C 
- intron 11 rs3924893 C=0.4  6/14 
c.1279T>A W399Re exon 12 -  A=0.0  1/14 
FAM108C1 c.*692T>C - 3'UTR rs1046417 C=0.130  2/14 
c.*1115C>A  - 3'UTR rs11072940 A=0.104  2/14 
KIAA1199 c.-255T>A - 5'UTR rs2273886 A=0.295  4/14 
c.1029+26C>
G 
- intron 7 - -  7/14 
c.1346+240C
>T 
- intron 9 - -  1/14 
c.1479+83T>
A 
- intron 10 - -  1/14 
c.2057+57A>
G 
- intron 13 rs2271164 G=0.417  5/12 
c.2142T>C C28C exon 14 rs2271160 C=0.261  3/14 
c.2462A>C - intron 16 rs2271162 C=0.167  3/14 
MESDC2 c.*3G>T - 3'UTR rs8039607 T=0.121  1/14 




- intron 4 -  Del=0.08 1/14 
c.*1416C>T - 3'UTR -  T=0.069  1/14 
c.*2153T>C - 3'UTR rs10519305  C=0.017  1/14 
C15ORF26 G496C>G - upstream rs2683255  -  1/14 
c.505-105insA - intron 3 -  -  3/14 
c.505-87C>G   intron 3 -  -  3/14 
c.664-50insA   intron 5 rs11395672  -   7/14 
TMC3 c.-13T>C - 5'UTR -    C=0.08 1/14 
c.580+55T>C   intron 6 rs12903128 C=0.345  1/14 
c.823-66A>G   intron 7 rs7167034 A=0.153  7/14 
Nucleotide variations are presented according to the HUGO nomenclature. Translation start site was used for each 
gene as the +1 nucleotide.
 
Putative effect on protein: 
a
 small, polar>polar, charged, positive, aromatic; 
b











In searching for the KS gene in the 15q24-25 region, we found 37 SNPs in 
the mRNA-coding sequences and promoters of 14 genes, including 6 
nonsynonymous codon changes. No evidently pathogenic mutations, such as the 
introduction of stop codons or frame-shift mutations, were detected. 
Given the rare occurrence of the disease (approximately 1:40 000), the 
expected cumulative frequency of all the disease variant(s) in the general population 
should be below 1%. We also sequenced fragments harboring variants in mRNA-
coding sequence in 96 control chromosomes (Table 2). One nonsynonymous amino-
acid change (W399R in ARNT2), and one silent codon change (A506G in AWP1) 
were not seen in the controls, suggesting that their frequencies might be as low as 
1%. However, each of these two variants (in two different genes) was found in 
heterozygous form in only a single patient, with no other possibly pathogenic 
complementary allele; these are therefore unlikely to represent the disease-causing 
mutations. None of the remaining SNPs were particularly rare and their occurrence 
in patients did not significantly deviate from population frequencies (Table 2). 
In conclusion, we did not find any variants that directly fulfilled the criteria 
of a pathogenic mutation for KS in any of the 21 genes located in the minimal gene-
containing region, as indicated by linkage analysis (while assuming the rare 
occurrence of the disease and the recessive mode of inheritance). The analyzed 
region may, however, contain pathogenic variants that we failed to find. We did not 
sequence introns that could contain regulatory elements or harbor gain-of-splicing 
site mutations. It is also possible that some of the genes have alternative exons not 
annotated in the current databases and thus not analyzed in our study, and we cannot 
exclude the possibility that some of the genes harbor heterozygous deletion(s) of one 
or more exons. We did not detect any extended homozygous regions, in neither the 
microsatellite data nor in the SNP data, but the relatively low density of 
heterozygous SNPs could have left some regions noninformative with respect to 
their purported hemizygosity (see Supplementary table 2). 
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As the pedigree structures in the cohort we studied were simple, we cannot 
exclude the possibility that some of the families are false positives, although none of 
the families was crucial for the significant LOD score. Hence, despite the statistical 
significance of the LOD score value, it cannot entirely be excluded that the 15q 
locus is a false positive locus. The current location of the linkage interval is based on 
two families (114 and 126; Figure 2) that contribute to the left recombination and on 
one family
18
 that contributes to the right recombination. This last family contains 
only one affected individual and, therefore, contributed very little to the overall 
LOD score. Under less stringent disease models, the linkage peak would still be 
significant with a 95% confidence interval matching the minimal gene-containing 
region. However, the linkage curve would be positive over a larger region with more 
than 200 genes. Hence, we cannot exclude that the KS gene is located closer to the 
15q telomere. Given that this larger region does not contain obvious candidate 
genes, more families will be needed to establish the exact KS region. 
 
Supplementary information  
https://www.dropbox.com/s/ad90beg26f1n1jb/suppl_data.doc 
 
Supplementary table 1. Clinical findings in 7 families selected for sequencing. 
Supplementary table 2. List of variations found in the seven KS patients. 
Supplementary figure 1. A representative EM picture showing lack of outer and 
inner dynein arms. 
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Gene expression studies in cells from primary ciliary 
dyskinesia patients identify 208 potential ciliary genes  
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Cilia are small cellular projections that either act as sensors (primary cilia) or propel 
fluid over the epithelia of various organs (motile cilia). The organellum has gained 
much attention lately because of its involvement in a group of human diseases called 
ciliopathies. Primary ciliary dyskinesia (PCD) is an autosomal recessive ciliopathy 
caused by mutations in cilia motility genes. The disease is characterized by recurrent 
respiratory tract infections due to the lack of an efficient mucociliary clearance. We 
performed whole-genome gene expression profiling in bronchial biopsies from PCD 
patients. We used the quality threshold clustering algorithm to identify groups of 
genes that revealed highly correlated RNA expression patterns in the biopsies. The 
largest cluster contained 372 genes and was significantly enriched for genes related 
to cilia. The database and literature search showed that 164 genes in this cluster were 
known cilia genes, strongly indicating that the remaining 208 genes were likely to be 
new cilia genes. The tissue expression pattern of the 208 new cilia genes and the 164 
known genes was consistent with the presence of motile cilia in a given tissue. The 
analysis of the upstream promotor sequences revealed evidence for RFX 
transcription factors binding site motif in both subgroups. Based on the correlated 
expression patterns in PCD-affected tissues, we identified 208 genes that we predict 
to be involved in cilia biology. Our predictions are based directly on the human 
material and not on model organisms. This list of genes provides candidate genes for 
PCD and other ciliopathies.  
 
Introduction 
Cilia are built on a scaffold of nine peripheral microtubule doublets. In motile cilia, 
the nine peripheral microtubule doublets are accompanied by two central 
microtubules (the 9+2 structure). Radial spokes connect the peripheral and central 
microtubules, while peripheral doublets are connected with each other by nexin 
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links. Outer and inner dynein arms are anchored to the peripheral microtubule 
doublet and produce the force needed for the movement of cilia. Synchronized 
beating of the cilia generates the flow of mucus and cerebrospinal fluid in the 
respiratory tract and in the brain, respectively, whereas in the fallopian tubes cilia 
help in moving the ovum toward the uterus. Flagella, built like motile cilia with a 
similar scheme of 9+2 microtubules, provide motility to unicellular organisms or 
cells, such as spermatozoa. Primary cilia—which lack the central pair of 
microtubules (the 9+0 structure), dynein arms and radial spokes—act as sensory 
organelles, displaying receptor molecules and sensing chemical and mechanical 
stimuli.
1
 However, it is important to note that motile cilia perform a variety of 
mechanosensory or chemosensory functions and primary cilia located, for example, 
on the embryonic node are motile.
2
  
Nevertheless, our understanding of the molecular composition of cilia is far 
from complete. Several approaches have been taken to characterize the cilia genome 
and proteome. Database search for tissue-specific expression pattern limited to 
ciliated tissues was used to predict 99 cilia related murine genes.
3
 Liquid 
chromatography-mass spectrometry of human epithelial cilia identified 164 
axonemal proteins.
4
 A mass spectrometry study of flagella of the unicellular alga 
Chlamydomonas reinhardtii identified 360 proteins very likely to be involved in 
cilia formation, and 292 that are probably involved.
5
 In addition, when comparing 
the genomes of non-ciliated organisms to ciliated organisms predicted 688 and 183 
cilia-related genes in Chlamydomonas reinhardtii
6
 and Drosophila melanogaster,
7
 
respectively. The presence of X-box promoter elements, which are targets of cilia-
related transcription factors, has led to the identification of additional ciliary genes 
in Caenorhabditis elegans.
8,9
 The results of these different studies have been 
assembled in online databases: the Ciliome Database
10
 and the Cilia Proteome 
database,
11
 which also contains basal bodies proteins. As far as human motile cilia 
are concerned, the database is probably far from complete since only a single high-
throughput proteomics study was performed on mammalian cilia.
4
 Most of what we 
know about cilia comes from work on the unicellular biflagellate alga 
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Chlamydomonas reinhardtiii. Although the evolutionary conservation of ciliary 
proteins is remarkably high, it can be assumed that mammalian cilia are more 
complex. Moreover, the genes related to the presence of multiple cilia in one 
epithelial cell, the genes associated with the coordinated beating of multiple cilia, as 
well as the genes coding for receptor molecules responsible for communication with 
the environment of the human body, are likely to be missing from the database.  
Defects in both primary and motile cilia have been associated with a group 
of pleiotropic, clinically overlapping, human diseases called ciliopathies, such as 
primary ciliary dyskinesia (PCD), polycystic liver and kidney disease, retinitis 
pigmentosa, nephronophthisis, Bardet–Biedl syndrome, Alstrom syndrome, and 
Meckel–Gruber syndrome.12, 13 PCD is a rare, genetically heterogeneous disorder 
caused by mutations in genes encoding proteins important for cilia motility.
14-22
 The 
disease is characterized by recurrent respiratory tract infections, bronchiectasis and 
infertility. Pulmonary symptoms occur due to the lack of an efficient mucociliary 
clearance caused by kinetic dysfunction of respiratory cilia. Male infertility is 
caused by immotility of flagella in spermatozoids. Situs inversus, a mirror reversal 
of thoracic organs positioning, is present in approximately half of the PCD patients 
because of immotility of primary cilia of the embryonic node. Nodal cilia are motile 
and generate leftward flow of extraembryonic fluid in the nodal pit. The flow has 
been identified as the initial left–right symmetry breaking event during 
embryogenesis. According to one of the hypotheses, the flow generates movement 
of nodal vesicular parcels to the left edge of the node. The parcels contain signaling 
molecules that activate signaling pathways. In case of immotility of nodal cilia, as in 
PCD, left–right determination is randomized causing situs inversus in approximately 
half of the patients.
23
 
We observed a down-regulation of the expression of dynein genes and other 
ciliary genes in PCD patients as compared to the controls (unpublished 
observations). More importantly, we noticed that more genes followed the pattern of 
dyneins expression in PCD patients, suggesting a functional relationship between the 
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co-regulated genes. We postulated that gene expression patterns in PCD patients 
could be used to identify mammalian cilia genes. For this study, we performed gene 
expression analysis on bronchial biopsies from PCD patients to identify groups of 
highly correlated cilia-related genes. In contrast to most of previous studies our 
predictions are based directly on the human material and not on model organisms. 
We report a cluster of 164 genes previously linked to cilia and 208 new genes that 
we predict will be involved in cilia-related processes.  
Materials and methods 
Bronchial biopsies 
We collected bronchial biopsies of six clinically diagnosed PCD patients and nine 
control subjects that were referred to the hospital for unrelated reasons. All patients 
had a saccharine test and light microscopy imaging of cilia motility characteristic for 
PCD. An electron microscopy evaluation of ciliary defects was performed, however, 
in two specimens an insufficient number of epithelial cells was recovered for 
inspection (Supplementary table 1). The concentration of nitric oxide (NO) in the 
nasal cavity was measured with a chemiluminescence analyzer, with a threshold 
value of 200 ppb for diagnosing PCD.
24
 Patient #1 had a concentration of nitric 
oxide in the nasal cavity little below the threshold and no electron microscopy 
imaging of cilia. Therefore, a second measurement of nitric oxide was performed 
confirming low concentration. He had a typical course of the disease with a 
resection of middle lobe due to necrosis and typical for PCD picture in 
bronchoscopic examination and nasal cavity examination. The specimens from non-
PCD controls were obtained through the same protocol; these individuals were 
referred to the Institute of Tuberculosis and Lung Diseases in Rabka, Poland for 
regular check-ups, with no symptoms of acute disease, with no bronchoscopic signs 
of the disturbance of mucociliary transport and with normal ciliary beating in the 
light microscopy. The study was ethically approved by the institutional review 




Anti-sense RNA was synthesized, amplified and purified using the Ambion Illumina 
TotalPrep Amplification Kit (Ambion, USA) following the manufacturer’s protocol. 
Complementary RNA was hybridized to Illumina HumanRef-12 Whole Genome 
BeadChips and scanned on the Illumina BeadArray Reader. The gene expression 
data has been submitted to GEO under accession number GSE11501.  
Data preprocessing 
The initial steps of data preprocessing and quantile normalization were performed in 
the Illumina BeadStudio Gene Expression module v3.2. Expression values below 5 
were thresholded to 5 and scaled by base 2 logarithm. We limited our data to 
Ensembl database v52 coding genes. The probes with an expression value variance 
in the lower 25% of the data were removed. To further limit the computations and to 
filter out genes not stably expressed in bronchial tissue, we removed probes not 
detected as present in 4/9 control individuals who had a diagnostic bronchoscopy, 
but did not display PCD symptoms. The remaining 13,811 probes were subject to 
clustering.  
Clustering 
The quality threshold (QT) clustering algorithm was implemented in C according to 
the algorithm described previously. The QT clustering algorithm performs a 
computationally extensive search for groups of correlated genes. It looks for largest 
cluster by iteratively putting every gene in the center of a potential cluster and 
adding to it genes with the highest Jackknife correlation coefficients in a way that 
minimizes the cluster diameter d, until no further genes can be added without 
exceeding a predefined d value.
25,26
 The quality of clusters was ensured by keeping 




For gene annotation enrichment analysis, we used the DAVID (Database for 
Annotation, Visualization, and Integrated Discovery: 
http://www.david.abcc.ncifcrf.gov/home.jsp).
27,28
 The tool calculates over-
representation of specific gene ontology terms with respect to the total number of 
genes assayed and annotated. DAVID applies a modified Fisher exact test, to 
establish if the proportion of genes falling into an annotation category significantly 
differs for a particular group of genes and the background group of genes. Ensembl 
Gene IDs of the cluster A genes were used as queries and the whole set of genes on 
the Illumina 12HT chip was used as the background group. The Ciliome Database 
(http://www.sfu.ca/~leroux/ciliome_home.htm) was queried with Ensembl Gene IDs 
of cluster A genes and Mouse Ensembl Gene IDs of theirs orthlologues to find 
known ciliary genes.
10
 The Ciliary Proteome Database 
(http://www.ciliaproteom.com)
11
 was queried with UniProt\SwissProt accessions of 
clusterA genes. Biomart module of the Ensembl database was used for ID\accession 
conversions. In addition, Pubmed was searched for publications linking individual 
genes to cilia or flagella.  
Tissue-specific expression 
The number of EST transcripts for analyzed gene in 30 different tissue types or 
organ pools was fetched from the UniGene database. Tissue expression enrichment 
scores were calculated as described in Yu et al.
29,30
 In brief, enrichment score ES i (g) 
= o i (g)/e i (g) is the ratio between observed to expected number of ESTs for gene g 
in tissue i. The total number of ESTs in UniGene for gene g is T(g) = ∑ i o i (g). 
Given the total size of EST libraries in tissue i, s i , the expected number of ESTs in 
tissue i for each gene is proportional to p i = s i /∑ i s i . For gene g, if it is expressed 
equally across all tissues, the expected number of ESTs in tissue i is equal to e i = 
T(g)p i . The mean enrichment scores of the analyzed groups of genes in each of the 
tissues were calculated and plotted for visualization of the tissue-specific expression 
patterns.  
Transcription factor-binding sites 
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Over-representation of transcription factor binding sites was evaluated in PAINT 
v3.9
31,32 
interfaced with the TRANSFAC Professional v 2009.2 database.
33
 The 500 
base pairs upstream from transcription starting sites were extracted from Ensembl 
database v52. A search for transcription factor binding sites was performed by the 
Match program with matrices deposited in the TRANSFAC database and filter 
option set to minimize false positives. p values were calculated using all human 
upstream sequences in the PAINT database as control group and false-discovery rate 
as the multiple testing correction.  
Results 
Clustering of genes based on the expression profiling of PCD tissue 
We performed whole-genome gene expression profiling in bronchial tissue of six 
PCD patients using Illumina HT-12 bead arrays. From the 48,803 probes on the 
arrays, 13,811 probes passed the filtering steps and were used for further analysis. 
We first used the QT (quality threshold) clustering algorithm to identify groups of 
correlated genes in PCD patients. We identified 12 clusters with more than 100 
genes; the clusters ranged in size from 100 (panel L, Figure 1) to 372 genes (panel 
A, Figure 1). We used DAVID (Database for Annotation, Visualization, and 
Integrated Discovery)
27,28
 to perform functional annotation enrichment analysis on 
all cluster members. DAVID applies a modified Fisher exact test to establish if the 
proportion of genes falling into an annotation category significantly differs for a 
particular group of genes and the background group of genes. The whole set of 
genes on the Illumina 12HT chip was used as the background group. The terms 
significantly enriched in cluster A were related to cilia, flagella and microtubules (p 
< 0.05 after Bonferroni’s correction) (Table 1). The remaining 11 clusters were not 
significantly enriched for terms that would have indicated a relation to a specific 
functional process. We also used DAVID to investigate the tissue expression 
patterns of the 372 genes in cluster A and found that they are mainly expressed in 





Figure 1. The 12 largest clusters of correlated genes obtained from bronchial tissue 








of genes % P-Value 
Bonferroni corrected 
p-value 
Microtubule-based process 15 3.9 1.10E-06 6.00E-03 
Microtubule cytoskeleton 28 7.3 5.50E-12 4.80E-09 
Axoneme 9 2.3 2.30E-10 2.00E-07 
Microtubule 20 5.2 3.10E-10 2.70E-07 
Cilium 10 2.6 6.50E-09 5.60E-06 
Dynein complex 9 2.3 2.40E-08 2.10E-05 
Cell projection 10 2.6 4.10E-08 3.60E-05 
Microtubule associated 13 3.4 8.90E-08 7.70E-05 
Cell projection 19 4.9 9.80E-07 8.50E-04 
Axonemal dynein 6 1.6 1.10E-06 9.30E-04 
Axoneme part 6 1.6 1.50E-06 1.30E-03 
Cytoskeletal part 27 7 3.70E-06 3.20E-03 
Microtubule motor 11 2.9 4.20E-07 1.20E-03 
 
Characterization of cluster A genes 
We queried the publicly available Ciliome Database
10
 to check how many members 
of our cluster A had been previously linked to cilia and found 121 genes to be 
present in this database. A similar search in the Ciliary Proteome Database
11
 resulted 
in classification of 115 genes as ciliary, 14 of which were not present in the Ciliome 
Database. A search in PubMed for publications linking cilia or flagella to any of the 
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individual genes from cluster A led to classification of an additional 29 ciliary 
genes, resulting in a total of 164 known ciliary genes (i.e. 44% of cluster A; 
Supplementary table 2). These results strongly suggest that cluster A is a ciliary 
gene cluster (binominal p < 1.10
−8
 if we assume 10% of human genes to be related 
to cilia). This would also suggest that the remaining 208 genes are related to cilia 
and these may represent new cilia genes not previously reported (Supplementary 
table 3). We observed the highest percentage of shared genes with the part of the 
Ciliome Database that was built on the results of experimental studies of motile cilia 
(Table 3). Cluster F (Figure 1) has an expression curve shape very similar to cluster 
A and 30% of the genes in cluster F also proved to be linked to cilia. However, we 
limited our analysis to cluster A genes only.  
 
Table 2. Tissue-specific expression enrichment analysis. Presence of a given gene in 
a tissue 3
rd
 quartile means that 75% of genes have a lower number of transcripts 
(ESTs) in the given tissue. The count and percentage of genes from cluster A is 
shown as well as statistical significance of over-representation in cluster A 
compared to the genomic control.  
UNIGENE EST Term Count % P-Value 
Bonferroni corrected 
p-value 
Testis 3rd quartile 230 59.9 8.90E-29 6.80E-27 
Lung 3rd quartile 202 52.6 9.30E-27 7.10E-25 
Uterine tumor 3rd quartile 153 39.8 5.50E-16 4.20E-14 
Trachea 3rd quartile 121 31.5 7.90E-13 6.00E-11 
Uterus 3rd quartile 135 35.2 1.10E-08 8.60E-07 
Brain 3rd quartile 171 44.5 2.20E-08 1.70E-06 




To further investigate tissue expression patterns of cluster A genes, we 
calculated expression enrichment scores for the 30 tissues from the Unigenes dbEST 
database.
29,30
 We performed the calculations both on the full set of cluster A genes 
and on two subsets of cluster A members: genes previously linked to cilia and the 
new genes identified in this study as potential ciliary genes. Each of the genes was 
given an enrichment score based on the ratio between the number of ESTs 
representing it in a given tissue and the expected number of ESTs for that gene in 
the tissue. The expected number of ESTs for a given gene was calculated assuming 
equal expression across all tissues. The mean enrichment scores for all cluster A 
genes and the subsets were calculated for each tissue to present the tissue-specific 
expression pattern of the genes (Figure 2).  
Table 3. The intersection of cluster A members and the Ciliome database 


































Method CG SAGE XBOX XBOX CG MS RNA MS MS 
Number 
of genes 
mapped to  
human genome 
 






31 16 24 11 56 67 38 44 22 
% of genes 
from each 
study in cluster 
A 
19.3 2.3 3.1 5.9 18.1 20.7 41.7 34.3 36.6 
CG comparative genomics; SAGE serial analysis of gene expression; XBOX X-box 





The mean enrichment score for cluster A genes and the two subsets was the 
highest for testis, trachea and lung, which are tissues known to have motile cilia. 
Brain tissue, where motile cilia are present in the ependyma, kidney and connective 
tissue having primary cilia, and the eye where rods and cones have a small 
connecting cilium, were ranked high; 8 out of the 10 highest ranking tissues were the 
same in the two subgroups of known ciliary genes and genes not previously linked 
to cilia.  
We screened the 500 base pairs (bp) upstream of each gene from cluster A 
for over-representation of transcription factor binding sites using PAINT v 3.9
31,32
 
and the TRANSFAC Professional v 2009.2 database
33
 (Table 3). The binding site for 
regulatory factor X (RFX) family of transcription factors was significantly over-
represented (false-discovery (FDR) rate adjusted p < 10
−6
) in the upstream 
sequences of cluster A genes, and in both the known and new ciliary genes in cluster 
A as well as in the “motile part” of the Ciliome Database (Table 4; Supplementary 
table 4).  
The expression of the cluster A genes in the control samples was stable, but 
not highly correlated (Figure 3a). The QT clustering in 6 controls returned 13 
clusters of more than 100 genes. None of the clusters was significantly enriched in 
annotation terms related to cilia. The biggest control cluster contained 383 genes 
(Figure 3b) and was not significantly enriched in any annotation term. Thirteen 
percent of genes in this cluster have been previously related to cilia, which was not 
statistically significant. The tissue expression pattern was different from cluster.  
A particularly the control cluster genes had much lower expression in testis. 
A similar pattern could be observed also for other control clusters (Figure 3d). The 
clustering performed in 6 patients together with 6 controls returned a cluster of 205 
genes with similar to cluster A pattern of expression in the patients and 171(83%) of 
genes present also in cluster A (Figure 3c). Forty-four percent of genes in this cluster 





Figure 2. Mean expression enrichment scores of genes from cluster A in 30 





Figure 3. The expression of 372 cluster A genes in 9 non-PCD control individuals 
(a). The biggest cluster of correlated gene expression in 6 control individuals (b). 
The biggest cluster in six control individuals and six patients showing a similar 
curve as cluster A (c). Tissue-specific expression pattern of five biggest control 
clusters (grey) and the cluster A (black). Cluster A is the only one with high relative 







Table 4. Over-representation of transcription factors binding sites in the 500 bp 
upstream sequences of cluster A genes and motile cilia genes from the Ciliome 
database. 
*Only the transcription factors that remained significant after multiple testing 
correction in all groups of genes are shown. 
§
All human  promoters sequences in 
PAINT databases were used as reference set. FDR false-discovery rate.  
 
Discussion 
We have identified a group of 208 new genes that are likely to be involved in cilia-
related processes. We used gene expression profiling of bronchial tissue from PCD 
patients to obtain a cluster of 372 genes with highly correlated expression. Forty-
four percent of the cluster members have been previously related to cilia based on 
high-throughput studies or individual experimental studies. The remainder of the 
cluster members is very likely to be cilia-related genes as they showed tissue-
specific expression patterns in accordance with the presence of cilia in the given 
tissues and they also showed over-presentation of RFX-binding sites in the upstream 
sequences. The tissue-specific expression pattern consistent with the presence of 
Transcription 
Factor* 
Cluster A (n=372) New ciliary prediction 
in cluster A (n=208) 
Known ciliary genes 















































































































cilia was seen for all 372 cluster genes, as well as 164 known ciliary genes and the 
208 cluster genes not previously linked to cilia. The expression libraries that we 
used for analysis of tissue-specific expression pattern were obtained from organs and 
tissues containing not only ciliated epithelium. Gene expression in different tissues 
containing ciliated cells has been successfully used to identify cilia-related genes.
3,34
 
High expression in axoneme-containing tissues, especially in testis, was unique for 
cluster A and not observed in control clusters. Bronchial biopsies are a compound 
source of RNA containing not exclusively ciliated epithelial cells.
35
 However, the 
gene expression pattern of the cluster A was extracted from patients and, therefore, 
is related to a disease that affects the function of ciliated cells.  
We found a statistically significant presence of the RFX transcription factors 
binding sites in the 500-bp upstream sequences of the all cluster A genes, known 
ciliary genes in the cluster A, and those not previously linked to cilia. In addition, 
we found RFX-binding sites in the upstream sequences of genes related to motile 
cilia and deposited in the Ciliome Database. The X-box-binding RFX transcription 
factors contain a highly homologous DNA-binding domain and share the same 
DNA-binding sites.
36
 RFX3, present among the 372 genes in the cluster A, is known 
to play a crucial role in the biogenesis of motile cilia.
37
  
Based on the sequence homology with Chlamydomonas reinhardtiii 
proteins, several human orthologs have been assigned to outer and inner dynein 
arms.
38
 The largest cluster in our analysis (cluster A) included genes encoding for 
proteins predicted to be part of outer dynein arms, like DNAH9, DNAI1 or DNAI2. 
Inner dynein arms were represented in this cluster by DNAH7, DNAH3, DNAH2, 
and WDR78. A number of known outer and inner dynein arm genes showed 
extremely low levels of expression and did not pass the filtering steps (DNAH14, 
DNAH17, TXNDC3 and DNAH8). DNAH6 and DNAH1 were not classified in our 
cluster A although they followed very similar expression patterns. DNAH5 and 
DNAH11 followed a different pattern of expression. Cluster A contained two genes 
known to be involved in building radial spoke complexes (RSHL3 and RSPH10B), 
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four intraflagellar transport proteins (IFT140, IFT172, IFT57, IFT74) and three 
genes coding for cytoplasmic dyneins (DYNC2LI1, DYNLL1, DYNLRB2), which 
play a role in the retrograde transport in the flagella in Chlamydomonas. Thirty-eight 
genes from cluster A have been shown to be mutated in human diseases and have 
entries in the OMIM database, including genes mutated in ciliopathies, such as 
Bardet–Biedl syndrome (BBS4, BBS5, BBS11), Meckel–Gruber syndrome (MKS1), 
nephronophtisis (NPHP1, NPHP2, NPHP3) and PCD (DNAI1, DNAI2, RSPH4A, 
RSPH9, LRRC50). Cluster A also contains two limb–girdle muscular dystrophy 
genes (FUKUTIN, TRIM32), one of which is also mutated in Bardet–Biedl 
syndrome (TRIM32), and three genes associated with retinitis pigmentosa (PDE6B, 
Pronin and RPGR). RPGR is known to cause a complex phenotype with both 
retinitis pigmentosa and PCD in some patients.
39
  
The ciliary proteome has been studied extensively using different high-
throughput methods, including mass spectrometry proteomic studies and 
comparative genomics. All studies, but one
4
 were performed in lower organisms and 
required a Blast search to identify possible human orthologs. Our ciliary set is based 
on the human transcriptome data, and this is one of our study’s strengths. Our 
dataset, however, might contain false-positive genes that matched the ciliary pattern 
by chance or are related uniquely to a pathology present in PCD. We based our 
prediction exclusively on PCD patients’ cells, what also limits our dataset to that 
part of a ciliary puzzle altered by this particular disease process.  
PCD is a highly heterogeneous disorder, for which nine genes are known to 
be mutated. Yet, in the majority of patients, the causative genes remain 
undiscovered. Our gene set could be considered a list of PCD candidate genes. 
Because one of the PCD loci is on chromosome 19q
40,41
 and we found three genes 
(CACNG6, C19ORF51 and AURKC) from our cluster that map to this region, they 
might well be considered disease candidate genes. A 1-bp deletion in the aurora 
kinase c gene (AURKC) has been associated with male infertility characterized by 
111 
 
large-headed, multi-flagellar, polyploid spermatozoa, what makes this gene an 
interesting candidate for further investigation in PCD patients.
42
 
The expression of cluster A genes was not highly correlated in the control 
samples. We observed a disease-specific pattern of expression for 372 functionally 
related genes. This phenomenon occurs in response to the mutation of a single gene, 
but most probably not the same gene in each patient studied, since PCD is a 
genetically heterogeneous disease. It indicates that information from the cytoplasm 
of the PCD epithelium, where cilia are misassembled
43
, is transferred to the nucleus 
and transformed on the genomic level into a regulatory signal altering expression of 
ciliary genes. Our results show how a monogenic disease affecting multi-protein 
complexes can be used to study more complex genomic networks.  
In conclusion, we identified a group of 208 new cilia-related genes. This list 
of genes provides candidate genes for PCD and other ciliopathies.  
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Chapter 5 
Ciliary genes are down-regulated in bronchial tissue of 
primary ciliary dyskinesia patients 
Maciej Geremek, Marcel Bruinenberg, Lude Franke, Ewa Ziętkiewicz, Andrzej 

















Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous disease 
characterized by recurrent respiratory tract infections, sinusitis, 
bronchiectasis and male infertility. The pulmonary phenotype in PCD is 
caused by the impaired motility of cilia in the respiratory epithelium, due to 
ultrastructural defects of these organelles.  We hypothesized that defects of 
multi-protein ciliary complexes should be reflected by gene expression 
changes in the respiratory epithelium. We have previously found that large 
group of genes functionally related to cilia share highly correlated expression 
pattern in PCD bronchial tissue. Here we performed an explorative analysis 
of  differential gene expression on the bronchial tissue from six PCD patients 
and nine non-PCD controls, using Illumina HumanRef-12 Whole Genome 
BeadChips. We observed 1,323 genes with at least two-fold difference in the 
mean expression level between the two groups (t-test p-value <0.05). 
Annotation analysis showed that the genes down-regulated in PCD biopsies 
(601) were significantly enriched for terms related to cilia, whereas the up-
regulated genes (722) were significantly enriched for terms related to mitosis 
and ribosomes. We assembled a list of human genes predicted to encode 
orthologs of flagellar proteins from Chlamydomonas reinhardtii: outer 
dynein arms, inner dynein arms, radial spokes, and intraflagellar transport 
proteins. A significant down-regulation of the expression of genes from all 
the four groups was observed in PCD, compared to non-PCD biopsies. Our 
data suggest that the down-regulation of the ciliome genes plays an important 





Cilia are small cellular projectiles, extending from the cell surface, with which they 
share the cell membrane. The ciliary axoneme is built on a scaffold of nine 
peripheral microtubule doublets, associated with many multi-protein complexes, 
including outer and inner dynein arms (ODA and IDA), nexin links and radial 
spokes. Cilia act either as sensors (primary cilia) or propel fluid over the epithelia of 
various organs (motile cilia)
1
; their dysfunction is the underlying cause of many 
systemic diseases. 
Primary ciliary dyskinesia (PCD) is a rare genetic disease characterized by 
recurrent respiratory tract infections, bronchiectasis and infertility. Pulmonary 
symptoms occur because of the lack of an efficient mucociliary clearance, caused by 
the kinetic dysfunction of the respiratory cilia. Male infertility is caused by the 
dysmotility of flagella in spermatozoids.  Situs inversus, a mirror reversal of body 
organ positioning, is present in approximately half of the PCD patients because of 
the immotility of primary cilia of the embryonic node.
2,3
 The diagnosis of PCD is 
based on the clinical criteria, the delayed saccharin test,
4
 and low levels of nasal 
nitric oxide.
5
 These symptoms are supported by the imaging studies of the 
respiratory cilia. Tissue specimens obtained through bronchoscopy are evaluated in 
the light microscope for ciliary beating and with the electron microscope for defects 
of the ciliary ultrastructure. Among a wide spectrum of various ultrastructural ciliary 
lesions documented in PCD patients
6
, the lack of ODA and/or IDA is the most 
frequently observed defect.  
PCD is an autosomal recessive trait with extensive genetic heterogeneity. To 
























. Products of most of these genes have conserved 
orthologs in Chlamydomonas reinhardtii and have a well-defined ultrastructural 
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localization in the axoneme. Collectively, all these genes explain only about one 
third of PCD cases.   
In search for a better understanding of the human cilia genome and proteome, 
we have performed gene expression profiling in PCD bronchial biopsies. We have 
previously found that large group of ciliary genes have highly correlated gene 
expression in 6 PCD bronchial biopsies. We applied cluster analysis to extract the 
pattern of expression of these ciliary genes and used that pattern to identify new 
genes involved in human cilia biology. Herein we report an explorative study of 
differential gene expression in PCD.  We performed gene expression profiling in 
bronchial biopsies from the six PCD patients and nine non-PCD controls. We report 
that the significant proportion of the genes that are down-regulated in PCD encode 
elements of the axonemal ultrastructure.  
 
Material and methods 
Bronchial biopsies and subjects 
Material for this study, obtained from six unrelated PCD patients and nine unrelated 
control individuals, has been described in detail in Geremek et al.
18
 Briefly,  clinical 
evaluation of the PCD patients was performed at the Institute of Tuberculosis and 
Lung Diseases in Rabka, Poland, by the experienced physician (AP). The primary 
bronchopulmonary symptoms in the patients were: sinusitis, nasal polyps, 
bronchiectasis, and recurrent infections of the upper respiratory tract. PCD status 
was also indicated by the positive results of routine diagnostic tests: the delayed 
saccharine test and lack of the ciliary motility in light microscopy imaging. In three 
patients (#1, 3, 4, 5) PCD diagnosis was confirmed by the low level of NO in the 
nasal cavity (chemiluminescence analyzer, the threshold value of 200 ppb)
5
 
(Supplementary table 1). The second patient (#2) had ODA defect and the sixth 
patient (#6) had IDA defect, but no NO data were available for both individuals. The 
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mutational status was known for one patient (patient #4), who was a compound 
heterozygote for two mutations in DNAH5. Non-PCD controls were individuals 
referred to the Institute of Tuberculosis and Lung Diseases in Rabka for different 
reasons unrelated to PCD; they presented no symptoms of acute pulmonary disease, 
no bronchoscopic signs of the disturbance of mucociliary transport, and had normal 
ciliary beating in the light microscopy.  
Biopsies were obtained during a diagnostic bronchoscopy, through the same 
protocol in PCD and non-PCD individuals. Specimens were stored in RNAlater 
buffer and used for RNA isolation. The informed consent was obtained from the 
participating patients. The study was approved by the appropriate local Ethics 
Committees. 
Gene expression analysis  
The quality and concentration of RNA were determined by using the 2100 
Bioanalyzer (Agilent, Amstelveen, The Netherlands) with the Agilent RNA 6000 
Nano Kit.  Anti-sense RNA was synthesized, amplified and purified using the 
Ambion Illumina TotalPrep Amplification Kit (Ambion, USA) following the 
manufacturer’s protocol. Complementary RNA was hybridized to Illumina 
HumanRef-12 Whole Genome BeadChips and scanned on the Illumina BeadArray 





Initial steps of data preprocessing, quantile normalization, background subtraction 
and quality control were performed using BeadStudio software. The data were 
exported to GeneSpring 9. Expression values with a threshold value below 5 were 
raised to 5, and the data were scaled by a base 2 logarithm.  
Fold-change analysis for all the probes was performed using GeneSpring 9 
software. Genes that had at least two-fold expression change (with an uncorrected t-
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test p-value<0.05) were subject to gene enrichment annotation analysis using 
DAVID (Database for Annotation, Visualization, and Integrated Discovery).
21
 
DAVID applies a modified Fisher exact test, to establish if the proportion of genes 
falling into an annotation category differs for a particular group of genes and the 
background group of genes (in this case, the whole set of genes on the Illumina 
12HT chip); the p-values were corrected for multiple testing using the FDR method. 
The resulting annotation terms were then clustered into functional groups.  
For the search of human orthologues of Chlamydomonas reinhardtii 
flagellar genes, the data were processed using the R package. The Ciliome database 
(www.ciliome.com)
22
 and PubMed were used as a reference for known ciliary genes. 
The mean expression values in the patients and controls were calculated, 
and a Wilcoxon Mann-Whitney test was used to obtain individual p-values. The 
unweighted Z-method of combining probabilities from independent tests was used to 
assess if the distribution of p-values deviated from normal.
23
 The Z-transform test 
converts one-tailed p-values, from each of the independent tests, into standard 
normal deviates; the sum of these standard normal deviates, divided by the square 
root of the number of tests, has a standard normal distribution if the common null 
hypothesis is true.  
 
Results 
Whole genome analysis (fold change and gene enrichment) 
We identified 1,323 genes (1,396 probes), which displayed at least 2-fold expression 
level difference in PCD compared to non-PCD bronchial tissue (t-test p-value 
<0.05); 722 of these genes (755 probes) were over-expressed, whereas 601 genes 
(641 probes) showed a reduced expression in PCD (Supplementary table 2). To 
investigate the biological meaning of these differentially expressed genes, we 
performed annotation enrichment analysis, separately for the up-regulated and 
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down-regulated genes, using DAVID software.
21
 Annotations of genes with the 
reduced expression in PCD patients were significantly enriched for terms related to 
microtubules, motility and cilia (Table 1). In the group of up-regulated genes,  four 
high-scoring annotation clusters were found: first related to mitotic spindle, cell 
cycle and mitosis, second related to ribosomes, ribonucleoprotein and translation, 
third related to cellular organelles, and last related to ribosomes  (Table 2). To 
investigate how many of the down- and up-regulated genes were functionally linked 
to cilia, the two groups (genes from Tables 1 and Table 2) were used to query the 
Ciliome database
20
 and PubMed. This search revealed that 105 (22%) of the down-
regulated and 46 (12%) of the up-regulated genes were related to cilia. Under a 
theoretical assumption that approximately 10% of the human genes are related to 
cilia (the Ciliome database contains 2024 entries), the proportion of ciliary genes 
found in the down-regulated group was significantly higher than in the whole set of 
genes on the Illumina 12HT chip (binominal p-value 0.0003).  The list of up-
regulated genes was not significantly enriched for genes related to cilia (p-value 
0.296967). 
 
Table 1. Gene annotation analysis of the 601 genes down-regulated in PCD (two-
fold change, and p<0.05) 
Functional Group 1 
Geometric p-value: 2.9868321894195106E-6 
GO Category Term Number of 
genes with the 
annotation term 
P-value FDR* 
cellular component axoneme part 10 1.64E-12 2.54E-09 
cellular component Axoneme 11 4.47E-12 6.93E-09 
cellular component dynein complex 13 7.23E-12 1.12E-08 
cellular component microtubule cytoskeleton 35 3.66E-11 5.67E-08 
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cellular component axonemal dynein complex 9 4.82E-11 7.47E-08 
cellular component cell projection part 14 1.56E-10 2.42E-07 
cellular component microtubule motor activity 15 5.00E-09 8.96E-06 
cellular component microtubule associated 
complex 
17 8.30E-09 1.29E-05 
cellular component cell projection 29 1.24E-08 1.92E-05 
biological process microtubule-based 
movement 
16 2.42E-08 4.63E-05 
biological process microtubule-based process 22 2.99E-08 5.72E-05 
biological process cytoskeleton-dependent 
intracellular transport 
17 4.07E-08 7.79E-05 
molecular function motor activity 18 1.60E-07 2.87E-04 
cellular component Microtubule 21 3.06E-07 4.75E-04 
biological process ciliary or flagellar motility 6 1.08E-06 0.002070472 
cellular component Cytoskeleton 50 7.87E-06 0.012198098 
*FDR false discovery rate. 
 
Table 2. Gene annotation analysis of the 722 genes up-regulated in PCD (two-fold 
change  and p<0.05) 
Functional Group 1 
Geometric p-value: 5.19460677949439E-8 
GO category Term Number of 




biological process mitotic cell cycle 28 1.04E-09 1.98E-06 
biological process cell cycle 49 2.15E-09 4.12E-06 
biological process M phase 26 2.48E-09 4.75E-06 
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biological process cell cycle process 44 3.03E-09 5.80E-06 
biological process cell cycle phase 28 1.07E-08 2.04E-05 
biological process Mitosis 22 1.88E-08 3.59E-05 
biological process M phase of 
mitotic cell cycle 
22 2.20E-08 4.21E-05 
biological process cell division 22 5.10E-08 9.75E-05 
Functional Group 2 
Geometric p-value: 7.2875016098167925E-6 
GO category Term Number of 














78 8.84E-10 1.37E-06 
Functional Group 3 
Geometric p-value: 6.297400435535407E-5 
GO category Term Number of 









24 1.21E-09 2.16E-06 
cellular 
component 
Ribosome 24 7.87E-09 1.22E-05 


























10 1.46E-05 0.022608839 
Functional Group 4 
Geometric p-value: 1.291005170513454E-4 
GO category Term Number of 




biological process DNA replication 19 6.98E-07 0.001335559 
biological process response to DNA 
damage stimulus 
20 4.90E-05 0.043594568 
*FDR false discovery rate 
 
Known ciliary genes 
To search for evidence of differential expression of genes related to specific 
axonemal structure elements, we assembled a list of proteins predicted to be a part of 
the known ultrastructural ciliary components.  For this purpose, we searched the 
literature for data linking individual proteins with particular ultrastructural 
components of flagella of Chlamydomonas reinhardtii. The selected proteins from 
the  alga were blasted against the human proteome, and the best scoring human 
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proteins, with the significance score higher than the arbitrary threshold of 1e-15, 
were assigned as orthologues. We also used data from Pazour et al.
24
, who applied 
phylogenetic analysis to assign human heavy dynein chains to ultrastructural 
components of flagella.  
The list of 47 human genes encoding proteins predicted to be a part of the known 
ultrastructural ciliary components included: 13 ODA genes, 14 IDA genes, 8 radial 
spoke genes and 12 intraflagellar transport genes (Table 3). These 47 genes were 
represented by 61 probes on the Illumina 12HT chip used here to characterize the 
level of expression in bronchial tissues from PCD patients and non-PCD controls. 
The mean expression levels in PCD and non-PCD bronchial tissues, and the 
corresponding Wilcoxon Mann-Whitney test p-values are presented in Table 3. Only 
3 of the 61 probes showed the higher expression level in the PCD group. The 
remaining 58 probes, representing 45 ciliary genes, indicated the lower expression 
level in PCD tissue. Significant differences between the levels of down-regulation in 
PCD and non-PCD groups were also observed when the p-values were calculated, 
using an unweighted Z-method,
23
 in four subgroups of genes encoding 
ultrastructural ciliary components: ODA, IDA, radial spoke and intraflagellar 
transport proteins (Table 3). 
 
Table 3. Differential gene expression of genes encoding outer dynein arms, inner 
dynein arms, radial spokes and intraflagellar transport proteins in the group of PCD 
cases compared to the non-PCD controls 
















Outer dynein arms 5.94E-07 
DNAH9 6400255 7.687516 9.826032 Down 0.002398 
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DNAH5 2350554 2.840433 5.349519 Down 0.010312 
DNAI1 2810300 8.674844 9.844953 Down 0.033167 
DNAI2 5960685 7.177193 8.689865 Down 0.002398 
DNAL1 2810500 6.708057 6.29279 Up 0.909491 
DNAL1 6100682 3.770269 5.508203 Down 0.005994 
TCTEX1D1 7560300 7.027727 8.381239 Down 0.043956 
CALM3 2750184 10.55856 10.60304 Down 0.431968 
DYNLRB2 5340725 10.71992 11.83949 Down 0.136064 
DNAL4 270678 10.26707 10.75581 Down 0.172674 
DYNLL1 6220086 12.17424 12.25021 Down 0.344456 
DYNLL2 3400551 6.986979 6.429329 Up 0.992199 
CCDC114 7210482 6.548517 8.35885 Down 0.005994 
DNAH11 7330360 3.002923 5.663427 Down 0.002598 
Inner dynein arms 2.59E-13 
DNAH7 6100661 6.514025 8.269907 Down 0.003796 
DNAH1 4900612 7.099972 8.823093 Down 0.002398 
DNHD2 1710253 8.860691 10.45194 Down 0.017982 
DNAH10 2000377 2.428852 3.237659 Down 0.014854 
DNAH3 2680059 5.769333 8.094914 Down 0.005605 
DNAH2 6860689 8.60512 10.73228 Down 0.001399 
DNHL1 7150161 3.006248 3.17991 Down 0.381969 
WDR63 5560730 6.41027 8.011633 Down 0.017982 
TCTEX1D2 1580021 8.612464 8.696081 Down 0.568032 
TCTEX1D2 7150433 11.46435 11.89049 Down 0.431968 
DNALI1 6200309 9.602157 11.071 Down 0.002398 
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DYNLT1 6350634 11.13857 11.51753 Down 0.136064 
CETN2 2120707 12.38314 13.28572 Down 0.08747 
WDR78 2360386 6.378204 8.079985 Down 0.012787 
WDR78 2650754 3.57718 5.360144 Down 0.019236 
WDR78 3190731 4.836388 5.143086 Down 0.612188 
DNAH11 7330360 3.002923 5.663427 Down 0.002598 
Radial spokes 4.16E-06 
RSPH3 2650678 7.413316 7.836832 Down 0.227972 
RSHL3 2630519 9.918507 10.80253 Down 0.163836 
RSHL3 4850241 9.109246 9.932796 Down 0.111888 
NME5 5290463 9.938878 10.88896 Down 0.264336 
RSPH1 6020451 10.40699 11.50298 Down 0.072328 
C6ORF206 840433 8.570299 9.296023 Down 0.163836 
RSPH10B 4060360 6.716065 8.128109 Down 0.02956 
RSPH10B 5810324 7.983313 9.466374 Down 0.008791 
PPIL6 3120259 6.766707 8.011536 Down 0.111888 
DNAJB13 1780309 4.103136 5.749771 Down 0.033167 
Intraflagellar transport complex 1.69E-10 
DYNC1H1 3450600 8.218894 8.928265 Down 0.033167 
IFT57 5700224 8.122991 9.303622 Down 0.033167 
IFT57 5700224 8.122991 9.303622 Down 0.033167 
IFT52 520367 6.271189 6.359964 Down 0.523515 
IFT52 520367 6.271189 6.359964 Down 0.523515 
IFT52 3420270 6.503832 6.703533 Down 0.136064 
IFT81 1090491 4.485731 5.681726 Down 0.072328 
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IFT81 7040706 3.850651 4.345121 Down 0.157369 
IFT88 3610537 5.57095 5.331608 Up 0.615962 
IFT88 4490253 2.321928 4.275251 Down 0.001754 
IFT88 5670288 7.041648 8.121763 Down 0.012787 
IFT122 1570687 6.441277 7.374693 Down 0.012787 
IFT122 4210463 7.780974 8.710176 Down 0.005994 
IFT122 5390554 3.13301 3.147856 Down 0.5 
IFT140 6960376 6.501864 7.674088 Down 0.017982 
DYNC2LI1 5720609 7.462295 7.494275 Down 0.344456 
DYNC2LI1 6520543 6.808812 7.84292 Down 0.024775 
IFT172 130070 8.232366 9.177806 Down 0.017982 
IFT57 5700224 8.122991 9.303622 Down 0.033167 
KIFAP3 1940482 8.670183 9.185607 Down 0.072328 
 
Discussion 
The gene expression profiling using the whole-genome Illumina panel, performed  
in bronchial biopsies from six PCD patients and nine non-PCD controls, revealed 
1,396 probes (representing 1,323 genes) with at least two-fold expression level 
difference between the PCD and non-PCD groups (t-test p-value < 0.05). A 
combination of the two-fold change with the significance measured by an 
uncorrected t-test, which takes into consideration the variance between the samples, 






 Functional annotation of the differentially expressed genes revealed that the 
down-regulated genes were related to microtubules, motility and cilia, and the up-
regulated genes to translation, ribosomes, cell cycle and mitosis.  
To further characterize the genes expression changes in the PCD, we 
compared expression levels of a number of cilia-related genes in the PCD and non-
PCD tissue. We assembled the list of 47 human orthologues of the Chlamydomonas 
reinhardtii flagellar proteins. The list was divided into three subgroups related to the 
ultrastructural components of motile cilia (outer dynein arms, inner dynein arms and 
radial spokes), plus one functional subgroup (intraflagellar transport proteins). In the 
analysis of bronchial biopsies from PCD patients, we demonstrated the reduced 
expression of the genes in all the four groups. Given the lack of linear relation 
between RNA and protein, we cannot make more specific conclusions about the 
possible correlation of the RNA level and the ultrastructural ciliary defect. Large 
multi-protein complexes of the dynein arms are pre-assembled in the cytoplasm, 
before their intraflagellar transport to the ciliary axonemes. Immunohisto-chemical 
staining of the ciliated epithelium from PCD patients with the identified DNAH5 
mutations has shown that not only the mutated DNAH5, but also DNAH9 protein 
was missing from the axonemes,  indicating that in patients with mutations in one of 
the ciliary genes, the delivery of other, non-mutated members of the ODA 
complexes to the cilium is impaired.
26
 Our data suggest that a regulatory system may 
exist, which – in the presence of a mutated ciliary gene – down-regulates the 
expression of the entire ciliary genome. Such a regulation would play an important 
role in the molecular pathomechanism of PCD.  
Of the genes known to be mutated in PCD
7-17
, six (DNAH5, DNAH11, 
DNAI1, DNAI2, RSPH4A, LRCC50) were down-regulated in the PCD patients 
examined in our study.  RSPH9 and Ktu/PF13 were equally expressed in the PCD 
and non-PCD samples, TXNDC3 and CCDC40 were not detected on the Illumina 
array and CCDC39 was not present on the array. The disease genes in several 
genomic regions reported to be linked to PCD (for the review see ref. 27), remain 
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not identified, mainly because of the noise in the linkage data, and because of 
difficulties in the functional prioritization of the candidate genes. In this context, 
observation of a down-regulation of the particular gene’s expression in PCD might 
provide clues for selecting candidate genes from the linkage peaks.  
To summarize, in our explorative study of gene expression in bronchial 
biopsies from PCD patients we found evidence of a significant down-regulation of 
the large group of cilia-related genes, predicted to encode elements of outer dynein 
arms, inner dynein arms, radial spokes, and intraflagellar transport proteins. These 
data suggest the existence of a regulatory system, capable of down-regulating the 
expression of the ciliome, which would play an important role in the molecular 
pathomechanism of PCD.  
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Primary ciliary dyskinesia (PCD) is a rare genetic disease characterized by recurrent 
respiratory tract infections, bronchiectasis and infertility. Pulmonary symptoms 
occur in PCD patients because of the lack of an efficient mucociliary clearance 
caused by immotility of respiratory cilia. Male infertility is caused by immotility of 
flagella in spermatozoids. The disease is genetically heterogeneous - mutations in 
many different genes have a similar functional effect on the motility of cilia and 
cause identical or similar phenotypes.  
We undertook two different strategies in an attempt to elucidate the 
pathogenesis of PCD. Firstly, we applied a classical genetic approach to look for 
new PCD loci and genes using linkage analysis and candidate gene sequencing. We 
identified a genomic region on chromosome 15q containing a gene mutated in a 
subtype of PCD called Kartagener syndrome, which is characterized by the presence 
of situs inversus in approximately  half of the affecteds in a pedigree. The 
Kartagener syndrome gene on chromosome 15q is still unknown. Secondly, we used 
a functional genomics approach to find new disease-associated pathways and 
functionally related genes in a genome-wide gene expression experiment. We 
identified 210 new ciliary genes through clustering analysis of the gene expression 
data. The results of our pilot gene expression analysis suggest that down-regulation 
of ciliary genes might be a general phenomenon in PCD and that, in the future, 
expression of selected genes might aid the diagnosis of the disease.  
The genes identified by the genomic approach represents a list of PCD 
candidate genes and should be enriched in ciliary genes related to the motility. A 
combined analysis of the chromosome 15q linkage region and results of the genomic 
approach is presented in figure 1. Several candidate genes can be pinpointed based 
on the clustering analysis and gene expression results. Five genes located in the 
linkage region or its surroundings are present in the ciliary cluster described in the 
chapter 4. Mutations were not found in C15ORF26. Interestingly, FAM154B located 
in close vicinity of the minimal linkage region described in chapter 3 is present in 
the ciliary cluster. Seven genes located in the linkage region or its surroundings were 
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downregulated in PCD bronchial biopsies. CCDC33 was downregulated in patient 
biopsies and is present in the ciliary cluster. Moreover it encodes a protein that 
contains a coiled-coil domain similarly to two PCD genes: CCDC39 and CCDC40.  
Several significant developments in the understanding of cilia proteomic 
composition, genetic control of cilia and ciliogenesis have occurred during the last 
few years. This progress was partially followed by medical genetic research in the 
field of PCD. Although several new disease genes have been identified, most of the 
cases still remain unexplained on the molecular level. The new PCD genes are 
mutated in only a few families or even in a single family. The main obstacle to 
finding more frequently mutated disease genes, if they exist, seems to be the 
disease’s extensive genetic heterogeneity in the absence of phenotypical diversity. 
This problem will be discussed further in the context of new technological 
developments in genomics. At the end of this chapter, the possible clinical relevance 
of medical genetics research for PCD patients will be discussed. 
Clinical homogeneity 
Accurate clinical work-up is a key issue in medical genetic research. It is, in a way, 
the first stage of linkage analysis. Assuming that the clinical picture differs in 
patients with mutations in different genes, careful phenotypical stratification of 
patients can reduce the genetic heterogeneity of the cohort under study. Compared to 
the other ciliopathies, the clinical picture of PCD is less diverse. The patients present 
with otitis media with effusion (95% of patients) and upper respiratory tract 
symptoms, like rhinosinustitis (100% of patients) .
1, 2
 Impaired mucociliary 
clearance in the lower respiratory tract results in recurrent bronchitis and 
pneumonia. Occurrence of bronchiectasis reflects the disease progression. The 
severity of the respiratory symptoms differs between affected individuals, however, 






Figure 1. Intersection of the genetic and the genomic approach. On the left a 
selection of chromosome 15 microsatellite markers and corresponding LOD scores 
are presented (see chapter 1). The blue bar represents the region analyzed by 
sequencing (see chapter 2). Genes present in the ciliary cluster A (see chapter 3) and 
genes that were up- or downregulated in the patient biopsies are presented on the 
right (see chapter 4).  
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Situs inversus totalis occurs in approximately 50% of PCD patients, while 
25% of patients with situs inversus have PCD. Therefore, the occurrence of 
respiratory symptoms together with abnormal visceral localization is a strong 
diagnostic indication. Mutations in DNAI1 and DNAH5, the two PCD genes that 
were characterized in large cohorts of patients, cause situs randomization.
3
 However, 
all the patients with mutations in RSPH9 and RSPH4A described so far have normal 
visceral localization.
4
 This suggests that for some PCD genes or mutations, cilia on 
the embryonic node are not affected despite the dyskinesia of respiratory cilia. 
Therefore, classification of families based on the presence of situs inversus might 
homogenize the studied cohort. 
The electron microscopy imaging of cilia is a routine way of classifying 
PCD families phenotypically. Mutations in genes coding for proteins comprising the 
outer and inner dynein arms cause defects in their respective ultrastructural 
elements. Electron microscopic (EM) imaging of cilia is the most widely used and 
most successful way of phenotypically stratifying patients for genetic studies, but it 
requires an invasive diagnostic protocol and is therefore not always available. 
Moreover, patients with mutations in the same gene do not always have the same 
ultrastructural defects and electron microscopy in patients with DNAH11 mutations 
shows normal ciliary ultrastructure .
5
 Immunostaining experiments with antibodies 
targeting dynein proteins have revealed the existence of at least two distinct outer 
dynein arms types in normal ciliated airway epithelium. This indicates that 
ultrastructural components of cilia seen in electron microscopy, like the outer dynein 
arms, are molecularly heterogeneous and, therefore, defects described in EM 
imaging might, in the future, be divided into more categories allowing for more 
accurate phenotyping.  
Females with PCD have reduced fertility and increased risk of ectopic 
pregnancy due to abnormal ciliary motility in the Fallopian tubes. Male infertility in 
PCD is caused by impaired motility of the sperm. However, some PCD patients are 





The analysis of semen in adult PCD males seems to be a promising tool for the 
phenotypical stratification of male patients. Some patients with outer dynein arms 
defects in respiratory cilia have normal dynein arms in the sperm tail. This might 
indicate that the genetic control of ciliogenesis is different in the epithelium to that 
in spermatoza. Ultrastructural and molecular analysis of ciliary and sperm 
axonemes, together with semen motility analysis, might allow groups of patients 
with related molecular defects to be identified in the future.  
Genetic heterogeneity 
The relatively low diversity in the clinical picture of PCD is, however, accompanied 
by an extensive genetic heterogeneity. Mutations in twelve genes have been found in 
PCD patients. Except for DNAH5 and DNAI1, which are mutated in approximately 
20% and 10% of patients, respectively, the remaining genes have been implicated in 
very few families. Two strategies in cloning novel PCD associated genes were 
successful: genetic linkage in large consanguineous families and a candidate gene 
approach based on functional studies of cilium in model organisms. The limitation 
of these successful study designs is that the importance of the given gene had to be 
established afterwards by sequencing in a larger cohort. Linkage analysis in multiple 
pedigrees, if successful, can point to a potentially important gene. However, gene 
mapping in heterogeneous diseases such as PCD is a difficult task since the data 
contains noise coming not only from false-positive signals but also from other true 
disease loci. 
Different aspects of ciliopathies can be understood in the context of cilia 
biology. Primary and motile cilia can be seen as two, not entirely independent, types 
of one organellum. Imaging, proteomic and gene expression studies indicate that 
genetic control, proteomic composition, ultrastructural and cellular organization, and 
the mechanism of ciliogenesis is at least partially shared by both types of cilia.
7, 8
 
Mutations of ciliary genes depend on the functional role played by the gene product 
affecting primary cilia, motile cilia or both of them. This explains the clinical 
overlap among the ciliopathies, i.e. the presence of situs inversus or respiratory 
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symptoms in primary cilia-associated diseases. Primary cilia can be found on many 
different cell types, which explains the clinical complexity of most of the 
ciliopathies. The PCD phenotype is less diverse because the disease is caused by 
dysfunction of only part of the ciliome related to motility.  
Large, multi-protein complexes of the dynein arms are pre-assembled in the 
cytoplasm before they get transported via intraflagellar transport to the ciliary 
axoneme. The delivery of outer dynein arms complex to the cilium is impaired in 
PCD respiratory epithelium.
9
 The presence in the cytoplasm of misassembled dynein 
arms could trigger the down-regulation of the ciliary genes expression. Therefore, 
the mechanism of dynein arm defects could be at least partly independent of the 
specific mutated gene. This would explain why genetic heterogeneity of PCD is not 
accompanied by heterogeneity in the phenotype.  
The impact of technological progress and translational research  
Although Mendelian disorders have a simple genetic disease model, several features 
make medical genetic analyses in this field complex. Many phenotypes of 
Mendelian diseases are extremely genetically heterogeneous, as in the case of 
deafness or retinitis pigmentosa that are caused by mutations in more than 100 
genes. Mutations in the same gene may lead to phenotypes that are inherited as 
dominant or recessive traits, as in the case of LMNA lesions causing autosomal 
dominant or recessive forms of Emery-Dreifuss muscular dystrophy.
10
 Digenic and 
triallelic inheritance has been described as a bridge between Mendelian and complex 
disorders. Pedigrees with Bardet-Biedl syndrome (BBS) have been identified in 
which three mutations at two different BBS loci segregate with expression of the 
disease traditionally classified as autosomal recessive ciliopathy.
11
  
We need to identify specific DNA changes in order to definitively diagnose 
diseases, and provide counseling and reliable prognostic information. Reduced 
sequencing costs and the development of next-generation sequencing is now 
revolutionizing medical genetic     research.
12, 13
 So far, large families were needed 
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for linkage analysis and homozygosity mapping in order to find and fine-map 
genomic regions prior to sequencing of candidate genes. Next-generation 
sequencing makes large sequencing projects possible and will enable us to discover 
mutated genes in the linkage regions. It might also enable direct identification of 
mutated genes by exome or genome sequencing. The pilot results from the 1000 
Genomes Project confirm the existence of thousands of low frequency and rare 
variants previously not described in both coding and non-coding DNA.
14
 But 
analysis of large amounts of sequencing data in the context of disease-causing 
variants is challenging. Some successes have been booked: for example, sequencing 
of a 12.5 Mb region linked to autosomal recessive cerebellar ataxia, together with 
bioinformatic prioritization of variants based on evolutionary conservation, has 
identified mutations in a new ataxia gene, ANO10.
15
 Whole genome sequencing in 
an individual suffering from Charcot-Marie-Tooth neuropathy revealed disease-
causing mutations in the SH3TC2 gene.
16
 The initial sequence analysis revealed 
9069 non-synonymous codon changes, including 121 nonsense mutations and 21 
described as causing Mendelian disease. The disease gene was found only after 
limiting the genes in focus to those previously implicated in neuropathic or related 
conditions. This illustrates the enormous power of next-generation technology, but 
also shows that its application is still limited by our incomplete knowledge of the 
variation in the human genome. Before this limitation is overcome, we will still need 
to select candidate genes. In ciliopathies, long lists of ciliome genes, based on high-
throughput proteomic and gene expression experiments, are already available. In the 
case of diseases with extensive genetic heterogeneity, such as PCD, which is at least 
partially characterized by private mutations present in only one or a few families, 
next-generation sequencing seems to be the method of choice for finding new genes, 
not only in unsolved linkage regions but also throughout the whole genome.  
One of the main challenges for medical genetics research is to translate the 
scientific progress into a knowledge-based clinical approach. PCD remains an 
underdiagnosed condition. The high genetic heterogeneity of PCD and the low 
frequency of mutations in the known PCD genes limit the application of DNA 
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diagnostics in clinical work-up. Currently, there is no gene-oriented clinical 
approach, so that the patient benefits only modestly from information about the 
specific gene mutation he/she carries. Electron microscopy of cilia obtained from the 
nasal cavity, together with NO measurements and functional testing of cilia motility, 
might provide enough information to establish the diagnosis of PCD. In uncertain 
cases, additional tests like cilia immunostaining or gene expression might aid the 
diagnostic process. However, it is possible that, in the future, in an era of 
personalized medicine, the genomic sequence of the patient will be available for 
mutation search.  
Functional studies of new PCD genes are needed before the genetic 
knowledge can be translated into therapeutic trials. Most of the PCD genes encode 
structural proteins, so that gene therapy holds the promise of successful treatment in 
the future, if the problem of vector delivery can be solved. As a proof of concept, 
DNAI1-deficient respiratory epithelial cell culture was transfected with cDNA 
containing the DNAI gene, and the immotile cilia recovered a normal beat and outer 
dynein arms reappeared.
17
 A significant number of mutations in DNAH5, so far the 
most important gene in PCD, are premature stop codon mutations. The 
aminoglycosides are known to promote nonsense mutation suppression. Thus, 
antibiotic treatment could circumvent the genetic defect in patients with premature 
stop codons due to nonsense mutations. The presence of even a small amount of the 
protein in the cytoplasm could restore the normal regulatory network of the gene 
expression and remove the blockade of ciliary gene expression in PCD. 
Concluding remarks 
Despite the significant progress made in PCD research, the field is challenging and 
many future projects can be envisaged. Although several new disease genes have 
been identified, most of the cases remain unexplained at the molecular level. PCD 
seems to be characterized by a large number of private mutations; even genes that 
have been previously screened in a large number of pedigrees with negative results 
are sometimes found to be mutated in another study. However, this extensive 
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heterogeneity is not accompanied by such diversity in the clinical picture. Two 
possible research directions can be envisaged to solve this problem. Firstly,  new 
diagnostic tools allowing high-resolution phenotyping could provide well-
homogenized cohorts of patients for a classical genetic approach. And secondly, 
developments in genomics, like next-generation sequencing technology, could make 
large scale analyses of individual genomes possible.  
High-resolution phenotyping based on immunostaining of specific ciliary 
components will allow further division of the currently known ultrastructural ciliary 
defects and enable genetic studies in more homogenous patient groups. Semen 
analysis has not yet been performed in a large group of PCD patients. The limited 
data that has been published so far suggests that semen analysis might be an 
interesting tool for stratifying the phenotypes of PCD patients.  
 Next-generation sequencing allows identification of mutations without 
needing extended pedigrees, which is important in a heterogeneous disease with 
infertility as a part of its clinical picture. Whole genome sequencing is still limited 
by the number of variations that have to be analyzed. However, in the case of ciliary 
genes, a large number of candidates can be selected based on high-throughput 
proteomic or gene expression data. Gene expression changes of ciliary genes seem 
to be an important aspect of PCD pathogenesis. Further analysis performed on a 
larger cohort of patients, and including bronchial biopsies from individuals with a 
known mutational status and ultrastructural defects, is needed to elucidate the role of 
global gene expression changes in the pathogenesis of PCD. 
Careful examination of a large cohort of PCD patients might point to new 
diseases rarely associated with PCD and therefore with cilia motility, as in the case 
of retinitis pigmentosa or mental retardation. Some diseases of unknown or complex 
etiology might be related to cilia motility. Hydrocephalus is part of a phenotype in 
many animal models of PCD. Although in man, hydrocephalus is not part of the 
classical clinical picture of PCD, cilia motility genes might be involved in 
normotensive hydrocephalus. Cilia motility genes also represent male infertility 
149 
 
candidate genes. Mutations in DNAH5, DNAH11 and DNAI1 have been described in 
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Motile cilia are small cellular projectiles that by synchronized beating propel fluid 
over the tissues. Cilia generate the flow of mucus and cerebrospinal fluid in the 
respiratory tract and in the brain, respectively, whereas in the Fallopian tubes cilia 
help to move the ovum toward the uterus. Flagella, built on a similar to cilia scheme, 
provide motility to spermatozoa. The motility of cilia plays an important role in 
initial left-right symmetry breaking event during embryogenesis. Primary ciliary 
dyskinesia (PCD) is a rare genetic disorder caused by mutations in genes 
functionally related to cilia motility. Lack of ciliary beating leads to recurrent 
respiratory tract infections and bronchiectasis because of defective mucociliary 
clearance. Kinetic dysfunction of the sperm tails causes infertility. Due to immotility 
of cilia on the embryonic node, left-right determination is randomized causing situs 
inversus in approximately half of the patients. PCD is inherited, in most of the cases, 
as autosomal recessive trait. The genetic heterogeneity of the disease is very high. 
Mutations in eleven genes have been identified in PCD patients so far. Despite this, 
large majority of cases remain unexplained on the molecular level. High genetic 
heterogeneity in conjunction with low diversity of the clinical phenotype makes 
difficult cloning of new genes by means of linkage analysis. Cilia are build of 
multiprotein complexes controlled by hundreds or even thousands of genes which 
makes selection of disease candidate genes a difficult task.  
In this thesis classical genetic and genomic approaches have been 
undertaken to study the pathogenesis of PCD. Chapter 2 describes genome wide 
linkage analysis in 70 PCD families. We hypothesized that genetic background of 
PCD might be different in families with Kartagener syndrome (KS), a subtype of 
PCD, that is characterized by situs inversus accompanying typical PCD symptoms. 
Therefore in order to reduce the genetic heterogeneity we divided PCD families in 
two subgroups : ciliary dysfunction-only (CDO) when all the patients in the family 
had situs solitus, and Kartagener syndrome (KS) when at least one patient in the 
family had situs inversus. We genotyped 462 microsatelite markers spread in the 
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genome in 52 KS and 18 CDO families. The maximal pairwise LOD score of 3.36 in 
the KS families indicated linkage of a KS locus to the long arm of chromosome 15. 
Genotyping of additional markers on chromosome 15q returned maximal pairwise 
LOD score of 4.34 for a marker localized in the chromosomal region 15q24-25. 
As described in chapter 3, in order to identify the KS gene on chromosome 
15q we focused on the minimal linkage region defined by the two closest 
recombination events. By genotyping additional microstatelite markers, the KS 
candidate region was refined to a 1.8 Mb segment containing 18 known genes. The 
coding regions of these genes and three neighboring genes were subjected to 
sequence analysis in 7 KS probands.  We found a number of single nucleotide 
sequence variants, some of which resided in mRNA coding sequences. However, 
none of the variations alone could explain the occurrence of the disease in these 
patients.  
The genomic approach enables analysis of functional changes of large group 
of genes occurring in a disease.  We hypothesized that defects of multi-protein 
complexes in PCD cilia  should be reflected by gene expression changes in the 
respiratory epithelium.  
In the analyses described in chapter 4 we used the Quality Threshold 
clustering algorithm to identify groups of genes that revealed highly correlated RNA 
expression patterns in the PCD biopsies. The largest cluster contained 372 genes and 
was significantly enriched for genes related to cilia. The database and literature 
search showed that 150 genes in this cluster were known cilia genes, strongly 
indicating that the remaining 210 genes were likely to be new cilia genes. The genes 
identified in our studies represents a list of PCD candidate genes and should be 
enriched in ciliary genes related to the motility.  
Chapter 5 describes an explorative analysis of differential gene expression in 
the bronchial tissue from six PCD patients and nine non-PCD controls, using 
Illumina HumanRef-12 Whole Genome BeadChips.  Annotation analysis showed 
that the genes down-regulated in PCD biopsies were significantly enriched for terms 
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related to cilia. Our data suggest that the down-regulation of the ciliome genes plays 











Trilharen (of cilia) zijn sterk gedifferentieerde structuren die specifieke cellulaire 
functies vervullen, zoals voortbeweging, waarneming van omgevingssignalen, of het 
geleidelijk naar buiten werken van de slijmlaag in de luchtwegen. Positionering van 
organen in het lichaam is deels ook afhankelijk van de werking van trilharen.  
Primaire ciliaire dyskinesie (PCD) is een erfelijke aandoening die gepaard 
gaat met een verminderde beweeglijkheid van de trilharen. Doordat hierdoor de 
luchtwegen worden aangetast, ontstaan er blijvende verwijdingen van de luchtwegen 
(bronchiën), aangeduid als bronchiëctasie en een chronische bijholteontsteking.  
Er bestaat ook een stoornis van de beweeglijkheid van de trilharen waarbij 
de organen in spiegelbeeld gepositioneerd zijn (situs inversus); deze noemt men wel 
het syndroom van Kartagener. 
In dit proefschrift wordt onderzoek gepresenteerd gericht op het ontrafelen 
van de oorzaak van PCD middels klassieke genetische en genomische studies.  
Het klassieke genetische onderzoek maakt gebruik van koppelingsonderzoek 
(linkage analyse). Dit onderzoek richt zich op het vinden van een ziektegen met 
behulp van zogenaamde genetische markers waarbij de overerving van het ziektegen 
dat de ziekte veroorzaakt, eenzelfde overervingspatroon volgt als de DNA marker. 
In hoofdstuk 2 wordt koppelingsonderzoek in 70 families met PCD 
beschreven. In deze studie is de aanname gedaan dat patiënten met het syndroom 
van Kartagener genetisch gezien andere afwijkingen hebben dan patiënten met PCD. 
Het hele erfelijke materiaal van 52 families met het syndroom van Kartagener is 
bekeken met 462 microstalliet markers. Eenzelfde studie is gedaan in 18 families 
met PCD.  Deze studie suggereerde dat genen op chromosoom 15q24-q25 betrokken 
zijn bij het syndroom van Kartagener (LOD score 4.34). 
In hoofdstuk 3 wordt verder ingezoomed op chromosoom 15q24-q25, 
specifiek in families met het syndroom van Kartagener. Door het testen van extra 
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genetische markers werd het chromosomale gebied gereduceerd tot 1.8 Mb; dit 
gebied bevat 18 verschillende genen die ieder voor zich positionele kandidaat genen 
zijn. Van ieder gen is het coderende deel bekeken op aanwezigheid van 
ziekteveroorzakende mutaties middels sequentie analyse in 7 onafhanelijke patiënten 
met het syndroom van Kartagener (afkomstig uit de meest veelbelovende families). 
De DNA sequentie analyse leverde een aantal variaties op, maar geen enkele variatie 
kon het voorkomen van het syndroom van Kartagener in de families verklaren. 
Met behulp van genoomonderzoek is het mogelijk om functionele 
verandering van grote groepen genen tegelijkertijd te onderzoeken. Dit onderzoek 
maakt gebruik van zogenaamde DNA-chips of microarrays. Hiermee kan heel snel 
en nauwkeurig DNA-materiaal van gezonde mensen en PCD patiënten worden 
vergeleken.  
In hoofdstuk 4 wordt beschreven welke genen tot expressie komen in 
weefsel van PCD patiënten. In deze studie is de aanname gedaan dat afwijkingen in 
de trilharen gereflecteerd worden door afwijkingen in de expressie van genen die 
onderdeel uit maken van de cellulaire trilhaar complexen in het epitheel van de 
luchtwegen. Met behulp van bioinformatica is een groep van 372 genen 
geidentificeerd, waarin 150 bekende cilia genen maar ook 210 nieuwe cilia genen. 
Deze 210 nieuwe cilia genen zijn interessante kandidaten om te testen voor 
genetische afwijkingen in families.  
In hoofdstuk 5 wordt heel specifiek het verschil onderzocht tussen PCD 
patiënten en gezonde mensen door wederom alle 22.000 genen in het menselijk 
genoom te onderzoeken. Ook dit onderzoek laat zien dat genen die deel uitmaken 
van cilia een afwijkend expressie patroon laten zien in PCD patiënten in vergelijking 
met gezonde controles. Het lijkt er met name op dat de cilia-gerelateerde genen lager 
tot expressie komen in PCD patiënten. 
 
